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ABSTRACT 
Psychotic disorders such as schizophrenia entail substantial suffering for the 
affected individuals and their networks. Traditionally, these disorders come as 
diagnosable entities that you either have or have not. However, recent 
epidemiological research has shown that symptoms of psychotic disorder, i.e., 
psychotic experiences, are common in the general population, especially during 
adolescence, and that these experiences are correlated with the development of 
psychosis. Thus, the traditionally binary psychosis phenotype can be extended to 
also include psychotic experiences. Despite efforts, little is known about the 
causes, correlates and consequences of the “extended psychosis phenotype”. 
Therefore, this thesis aimed to shed new light on these aspects of this broadly 
defined psychosis phenomenon. 
In studies I and II, data from the Child and Adolescent Twin Study in Sweden 
(CATSS) were used to examine childhood neuropsychiatric problems (here 
language and mathematical problems, autistic traits, and general neuropsychiatric 
problems) as risk factors of adolescent psychotic experience (and juvenile mania 
symptoms). When possible, twin models were additionally used to disentangle 
the relative contributions of genetic and environmental influences in the 
observed associations. Results showed that childhood problems with 
communication, reading and mathematics, but not speech, predicted adolescent 
psychotic experiences. Further, it was found that the association between 
childhood autistic traits was explained by general neuropsychiatric problems. 
The twin models revealed that the same set of genes produce susceptibility for 
the studied childhood neuropsychiatric problems and adolescent psychotic 
experiences. 
In study III, data from the National Patient Register was used to determine if 
Darier disease, a rare skin disease, would correlate with schizophrenia or bipolar 
disorder in the general population. The hypothesis was based on the shared 
common ectodermal origin of skin and brain. We found that individuals with 
Darier disease had a 2-fold elevated risk of being diagnosed with schizophrenia, 
and a 4-fold excess risk of being diagnosed with bipolar disorder, compared with 
matched comparison subjects. 
 In study IV, CATSS data was linked to the National Patient Register to examine 
consequences of adolescent psychotic experiences. Results revealed that 
adolescents reporting psychotic experiences had elevated risks of being 
diagnosed with alcohol or substance misuse, or suicide attempt.  
In sum, we found that adolescent psychotic experiences are neurodevelopmental 
phenomena that share genetic etiological factors with childhood neuropsychiatric 
problems. Further, we demonstrated population associations between Darier 
disease and schizophrenia, and bipolar disorder. Lastly, we observed that 
adolescent psychotic experiences are associated with adverse consequences.  
These results confirm the neurodevelopmental origin of the extended psychosis 
phenotype, including psychotic experiences, and highlight the need for cross-
professional monitoring of adolescents reporting psychotic experiences. 
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1 BACKGROUND 
1.1 A BRIEF INTRODUCTION TO RESEARCH INTO RISKS, 
CORRELATES AND CONSEQUENCES OF PSYCHOSIS 
Hallucinations and delusions are probably as old as the human species, and have 
historically been regarded as intercessions from gods or demons (Kelleher, 
Jenner & Cannon, 2010). In modern times, however, such perceptual 
experiences have until recently generally been seen as signs of psychotic illness, 
but as discussed in subsequent sections of this thesis, findings from 
epidemiological studies have challenged our understanding of psychotic 
phenomena. 
As the matter of fact, epidemiological research has played a central role in the 
history of psychosis research, and ever since the first psychosis researchers 
interviewed their patients about their developmental histories (e.g. Bleuler, 
1911/1950), there has been an appreciation of the notion that the developmental 
trajectories of children who will develop a psychotic disorder as adults differ in 
important ways from children who will not develop a psychotic disorder. A 
number of small, but nevertheless interesting, studies followed-up and 
confirmed the initial observations made by Bleuler, including a number of papers 
from the pioneers Barbara Fish (e.g. Fish,1957) and Israel Kolvin (e.g. Kolvin et 
al., 1971).  
Decades later, when the first large birth cohorts were established in England and 
New Zeeland, several prospective studies, where children were observed from 
early childhood into adulthood, provided robust evidence for a range of 
developmental deficits across domains of cognition, motor and social behavior 
in children who would develop schizophrenia as adults (Jones et al., 1994; Done 
et al., 1994; Cannon et al., 2002). Clearly, these large-scale prospective studies 
have contributed substantially to the understanding of the etiology of 
schizophrenia. This research field has recently started to explore risk factors of 
psychotic symptoms in the general population (i.e., psychotic experiences), an 
area that might provide additional clues to the etiology of schizophrenia and has 
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several advantages compared with research based on individuals with 
schizophrenia. For example, samples sizes are considerably larger, there is 
virtually no interference from psychotropic drugs, and secondary illness effects 
does not constitute a major problem (David, 2010; Rössler et al., 2011). Still, at 
the time of writing, only a couple of studies have used longitudinal data to 
examine risk factors of psychotic experiences in the general population.  
Even though the so called “Kraepelinian dichotomy”, that is, the division of 
psychotic and bipolar (affective) disorders, has been preserved in Western 
psychiatry for more than a century, several etiological and clinical elements are 
shared between schizophrenia and bipolar disorder, as evidenced by the 
invention of the intermediate category schizoaffective disorder (Murray et al., 
2004; Craddock & Owen, 2010). However, despite the substantial genetic 
overlap between the disorders (Lichtenstein et al., 2009), epidemiological studies 
have also shown that several important differences are present, for example 
regarding neurodevelopment; children who will develop bipolar disorder as 
adults do not differ from children who will not, with regards to characteristics 
associated with schizophrenia development (Murray et al., 2004).  
The co-occurrence of schizophrenia, or bipolar disorder, with other psychiatric 
disorders is relatively well studied (Buckley et al., 2009), and in addition, some 
physical disorders seem to occur more often in these disorders than what would 
be expected by chance. Such “comorbid” conditions can also be referred to as 
correlates. An increasingly popular extension of studies of correlates of 
schizophrenia is to also examine the occurrence of the “other” disorder in 
relatives to individuals with schizophrenia. By doing so, it is possible to elucidate 
if two disorder occur as a result of shared familial (including genetic) risk factors.  
The consequences of psychosis is also a long-standing research area, and it is 
now well established that for example schizophrenia increases mortality and 
produces social ill health and deprivation. However, surprisingly little is known 
about consequences of adolescent psychotic experiences, even though studies 
have shown that they are associated with elevated risk of adult psychotic 
disorder (Poulton et al., 2000) and suicidal behavior (Kelleher et al., 2013a). 
Given the continuity between psychotic experiences and schizophrenia, it is 
conceivable that consequences of schizophrenia also apply to adolescent 
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psychotic experiences. This possibility has not been explored sufficiently to date, 
most probably due to a lack of longitudinal datasets with large enough sample 
sizes. 
1.2 SCHIZOPHRENIA 
Schizophrenia is a psychotic disorder that has been described as the worst 
disorder affecting mankind (Tandon et al., 2008), and it is arguably the most 
classic psychiatric disorder. This is because in contrast to most other psychiatric 
disorders, the features that define the disorder have remained essentially 
unchanged for more than a century (Heckers et al., 2013). Schizophrenia is a top 
ten cause of disease-related disability (World Health Organization, 2001) and 
affects about 0.7% of the population (Saha et al., 2005). The disorder is 
characterized by positive symptoms (e.g., hallucinations, delusions and 
disorganized thought/speech processes), negative symptoms (e.g., anhedonia 
and lack of activity), but also cognitive disturbances such as problems with 
attention, concentration and memory. The age of onset is usually in the early 
twenties, with a slightly later onset in women than in men (Häfner et al., 1992). 
Schizophrenia was originally defined by Emil Kraepelin (1904, 1919), who 
conceptualized the disorder as an early onset and rapidly deteriorating form of 
dementia, which he labeled “dementia praecox”. A few years later, the Swiss 
psychiatrist Eugen Bleuler (1911/1950) essentially validated Kraepelins 
observations and coined the term schizophrenia, as he did not agree with the 
concept of rapid deterioration from onset to dementia. Bleuler also added 
further details to diagnostics, by describing how certain cognitive and affective 
functions become distorted and/or disorganized in the disorder (McGlashan, 
2011). As an example, he described the content of auditory hallucinations in the 
following way: 
“The voices not only speak to the patient, but they pass electricity 
through the body, beat him, paralyze him, take his thoughts away..“ 
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In this description, one can extract perceptual (“The voices not only speak to the 
patient..”), emotional (..”beat him, paralyze him”), and cognitive (“..take his 
thoughts away..”) components in the hallucinations. Bleuler’s descriptions 
became very influential for the diagnostic criteria in the first version of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM, APA 1952).  
A couple of decades after the major contributions of Bleuler was published, Kurt 
Schneider paved the way for a schizophrenia definition that emphasized 
psychotic symptoms much more than did Kraepelin and Bleuler (Schneider, 
1959). These symptoms, i.e., auditory hallucinations and delusions, have since 
then been referred to as “Schneiderian first-rank symptoms”, and formed a 
central part of the diagnosis from the DSM-III to the present version 
(Moscowitz & Heim, 2011; APA, 2013). 
The DSM-5 (APA, 2013), which puts less emphasis on the distinction between 
schizophrenia and other psychotic disorders than previous versions, define 
psychotic disorders through five domains of psychopathology: hallucinations, 
delusions, disorganized thought/speech, negative symptoms, and 
disorganized/abnormal motor behavior. In addition, gradients and dimension of 
psychosis have been introduced, with the ambition to capture more of the 
considerable variability regarding outcomes, social functioning, response to 
treatment, and symptom profile that characterizes psychotic disorders. In this 
context, the current definition of schizophrenia necessitates that it lasts for more 
than one month, is not secondary to some other disorder, involve at least two 
psychopathological domains, and that there is a decrease in the level of 
functioning below the level achieved before to the onset of the clinical disorder 
(Heckers et al., 2013). Even though this definition is indeed similar to earlier 
versions of the DSM, it apparently tries to capture the dimensional structure of 
psychosis, albeit within the frames of a traditional categorical system. 
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1.2.1 Etiology 
Despite extensive efforts and long-standing research, the etiology of 
schizophrenia has remained an enigma for decades, and is still not very well 
understood. Familial factors, and especially genetic factors, have been strongly 
implicated; twin studies indicate a heritability of around 80% (Sullivan, Kendler 
and Neale, 2003) and the recurrence risk, i.e., the risk of schizophrenia in first-
degree relatives to individuals with the disorder, is increased by a factor of ten 
(Lichtenstein et al., 2006).  
Recently, a progress seldom seen in psychiatry research has been observed in the 
area of molecular genetic schizophrenia research: the most recent genome-wide 
association study (GWAS) from the Schizophrenia Working Group of the 
Psychiatric Genomic consortium (2014) has provided important clues into 
etiological processes of the disorder. In this study, 108 (about 130 in the latest 
unpublished data) biologically plausible locations in the genome (i.e., loci) were 
identified, out of which 83 had not been reported previously. Several identified 
risk loci included genes involved in glutamatergic transmission and synaptic 
plasticity, which is consistent with one of the leading pathophysiological theories 
of schizophrenia (Javitt, 2012). One of the other most influential theories, the 
dopamine hypothesis, which postulates that the disorder is closely related to an 
excess of dopamine-relation neuronal activity (Meltzer & Stahl, 1976) was also 
supported in the study, as an association probably implicating the dopamine D2 
receptor gene and schizophrenia was observed (O’Donovan, 2015). Further, 
epidemiological findings have suggested that dysregulation in the immune system 
is causally linked to schizophrenia (Benros, Mortensen & Eaton, 2012). This 
hypothesis, commonly referred to as the immunological hypothesis of 
schizophrenia, was also supported, as associations were enriched at enhancers 
that are active in tissues involved in immunological functioning. Finally, 
associations with schizophrenia were markedly enriched at brain-relevant 
enhancers, providing tentative support for a neurodevelopmental component in 
the etiology of schizophrenia, in keeping with the neurodevelopmental model of 
the disorder. 
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1.2.2 The neurodevelopmental model   
A model of great heuristic importance for the etiology of schizophrenia is the 
neurodevelopmental model, which was formulated almost 30 years ago (Murray 
& Lewis, 1987; Weinberger, 1987). This model, today supported by evidence 
from several lines of research, posits that the frank disorder is the consequence 
of aberrant neurodevelopmental processes or events that occur well before the 
onset of the clinical disorder. Even though the temporality is essential in this 
model, the negative genetic and/or environmental “hits” and processes can 
occur anywhere from the time of conception to late adolescence. It should be 
noted that the concept of premorbid aberrations in schizophrenia date back to 
the days of Bleuler (1911/1950) and Kraepelin (1919), who used retrospective 
patient interview data to pinpoint the illness course from before the first 
prodromal symptoms, to the onset of the overt disorder. 
Apparently, neurodevelopmental models vary substantially with regards to the 
timing and specificity of the genetic and environmental insults of interest, but 
the majority of research has focused on prenatal brain development (Rapoport et 
al., 2005). 
1.2.3 Precursors  
In keeping with the neurodevelopmental model, a plethora of studies have 
identified a wide range of neurodevelopmental problems and deviations in 
children who will later develop schizophrenia, compared with children who will 
develop other non-psychotic psychiatric disorders, or no psychiatric disorder at 
all. Starting with obstetric complications, it has been found that especially 
complications during pregnancy (e.g. diabetes), problems with fetal growth and 
status at delivery (e.g. low birth weight or small head circumference), and 
delivery complications (e.g. caesarian section or lack of oxygen) are related to an 
elevated risk of schizophrenia (Fish, 1992; Cannon, Jones & Murray, 2002; 
Rapoport et al., 2005). The causal nature of such complications in etiology of 
schizophrenia is usually assumed (Rapoport et al., 2005), but somewhat difficult 
to corroborate based on available data; there is always a possibility that the 
associations are due to a shared liability of both for example infections and 
psychiatric disorder. 
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A host of research implicates pan-domain neurodevelopmental disturbances in 
early childhood as important features in the developmental trajectories of 
psychosis. For example, Kolvin and colleagues (1971), and Crow et al. (1995) 
found that childhood (expressive) language and mathematical problems were 
important in the development of schizophrenia. Furthermore, in influential 
studies, childhood problems with motor behavior (Walker, Savoie & Davis, 
1994; Erlenmeyer-Kimling et al., 2000 ) and receptive language (Cannon et al., 
2002) were associated with adult psychotic disorder. In the same vein, two 
British and one Australian birth cohort studies (Jones et al., 1994; Done et al., 
1994; Welham et al., 2010) have evidenced that delays in speech and/or motor 
development predict later psychosis. Pre-morbid developmental deficits have 
been documented also in other cognitive domains, as well as in social capabilities 
(Jones et al., 1994; Done et al., 1994, Olin & Mednick, 1996; Cannon et al., 
2002). 
A relatively recent study has presented data suggesting that a (relative) decline in 
verbal ability and other cognitive abilities during adolescence are associated with 
elevated risks of adult psychosis, but only in men (MacCabe et al., 2013). This 
novel and intriguing finding indicates that disturbance also in late 
neurodevelopment may be part of the trajectory to psychosis for some 
individuals, and is in line with the brain changes reported in adolescents who will 
later develop schizophrenia (Pantelis et al., 2003; Rapoport et al., 2005). Notably, 
the degree of the impairments described above is associated with earlier age of 
onset and severity of schizophrenia in a dose-response fashion (Rapoport et al., 
2005), which indicates that these ongoing premorbid processes could be causally 
related to schizophrenia. 
It is well established that adult schizophrenia more often than not is preceded by 
a childhood-onset psychiatric disorder. Premorbid psychopathologies are thus 
important precursors of schizophrenia, which was demonstrated in an elegant 
and influential paper by Julia Kim-Cohen (2003). She performed a follow-back 
analysis of a prospective cohort study, and found that 74% of individuals with 
schizophrenia had received a psychiatric diagnosis before age 18 and 50% before 
age 15. In her study, the commonest pre-psychotic disorders were conduct 
disorder and anxiety disorder. Further, many researchers have focused on the 
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earliest so-called “prodromal” phases of psychosis. In essence, the psychosis 
prodrome denotes a pre-psychotic disturbance representing deviations from 
previous experiences and behaviors (Yung & McGorry, 1996). According to 
Alison Yung and Patrick McGorry, two Australian pioneers in this research field, 
the psychosis prodrome is a highly significant condition, as it is: 
“.. potentially important for early diagnosis and management of 
psychotic disorders, early detection of relapse, prospective studies of 
high-risk individuals, and prognosis” (Yung & McGorry, 1996, p. 
355).  
The most commonly described signs and symptoms of prodromal psychosis are 
presented in Table 1.2.3, in alphabetical order. 
Table 1.2.3. Signs and symptoms of prodromal psychosis. 
Symptoms  References 
Anhedonia Chapman, 1966; Docherty et al., 1978; Huber et al., 1980; 
Hambrecht et al.,1994; Addington et al., 2015. 
Anxiety Docherty et al., 1978; Subotnik & Neuchterlein, 1988; 
Häfner et al., 1992; Hambrecht et al., 1994; Meyer et al., 
2005. 
Apathy Chapman, 1966; Docherty et al., 1978; Häfner et al., 
1992; Hambrecht et al., 1994. 
Concentration 
problems 
Chapman, 1966; Huber et al., 1980; Heinrichs & 
Carpenter, 1985; Häfner et al., 1992; Hambrecht et al., 
1994; Meyer et al., 2005; Aston et al., 2012; Addington et 
al., 2015. 
Decreased general 
functioning 
Bleuler,1911/1950; Kraepelin, 1919; Chapman, 1966; 
Huber et al., 1980;  Häfner et al., 1992; Cornblatt et al., 
2003. 
Changes in sense of 
self or other people 
Chapman, 1966; Stein, 1967; Huber et al., 1980; Häfner et 
al., 1992; Hambrecht et al., 1994. 
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Depression Chapman, 1966; Huber et al., 1980; Birchwood et al., 
1989; Hambrecht et al., 1994; Meyer et al., 2005; Aston et 
al., 2012. 
Disruptive 
behaviors 
Varsamis & Adamson, 1971; Heinrichs & Carpenter, 
1985; Subotnik & Neuchterlein, 1988; Häfner et al., 1992; 
Meyer et al., 2005. 
Guilt feelings Subotnik & Neuchterlein, 1988; Häfner et al., 1992; 
Hambrecht et al., 1994. 
Irritability Bleuler, 1911/1950; Chapman, 1966; Docherty et al., 
1978; Hambrecht et al. 1994; Aston et al., 2012. 
Obsessive-
compulsive 
symptoms 
Bleuler, 1911/1950; Chapman, 1966; Docherty et al, 
1978; Hambrecht et al., 1994; Meyer et al., 2005; 
Niendam et al., 2009. 
Perceptual 
abnormalities 
Chapman, 1966; Bowers, 1968; Varsamis & Adamson, 
1971; Subotnik & Neuchterlein, 1988; Hambrecht et al., 
1994; Schultze-Lutter et al., 2012; Addington et al., 2015. 
Psychosomatic 
complaints 
Bleuler, 1911/1950; Huber et al., 1980; Heinrichs & 
Carpenter, 1985; Häfner et al., 1992; Hambrecht et al., 
1994; Meyer et al., 2005 
Sleep disturbance Bowers, 1968; Huber et al.,1980; Heinrichs & Carpenter, 
1985; Häfner et al., 1992; Hambrecht et al., 1994; Aston 
et al., 2012; Addington et al., 2015. 
Social withdrawal Chapman, 1966; Docherty et al., 1978; Birchwood et al., 
1989; Häfner et al., 1992; Hambrecht et al., 1994; 
Cornblatt et al., 2003; Meyer et al., 2005; Aston et al., 
2012; Addington et al., 2015. 
Suspiciousness Stein, 1967; Varsamis & Adamson, 1971; Subotnik & 
Neuchterlein 1988; Birchwood et al., 1989; Hambrecht et 
al., 1994; Schultze-Lutter et al., 2012; Addington et al., 
2015. 
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As presented in Table 1.2.3, the prodromal signs and symptoms are notoriously 
unspecific to psychosis. Yung & McGorry (1996, p. 361) have described that the 
typical pathway from these first prodromal phenomena to the first “frank” 
psychotic symptoms goes via a trajectory including attenuated psychotic 
symptoms, accompanied by changes in behavior. Several other possible 
trajectories have however been suggested, for example by James Chapman 
(1966), who believed that the initial prodromal phase consisted of “psychosis-
specific” subjective cognitive symptoms, such as problems to attend to relevant 
information, and conversely, to filter out irrelevant information, which were then 
followed by apparent behavior changes (e.g. problems with motility and speech). 
Chapmans view was that these particular symptoms and signs occur well before 
any overt psychotic symptoms become evident. 
1.2.4 Correlates  
Research has clearly shown that individuals with schizophrenia have elevated 
rates of an extensive selection of adverse disorders and conditions, ranging from 
other psychiatric disorders and somatic disorders, to socio-economic deprivation 
(Wicks et al., 2005). Such co-occurring phenomena are usually referred to as 
correlates, although this term is most commonly used to describe cross-sectional 
data. Table 1.2.4 lists the most frequently reported correlates that are relevant for 
this thesis, namely psychiatric and somatic disorders, in alphabetical order. 
 
Table 1.2.4. Frequently reported correlates of schizophrenia. 
Correlate References 
Psychiatric disorders  
Major affective 
disorders  
McGlashan & Carpenter, 1976; Elk et al., 1986; 
Kendler et al., 1993. 
Alcohol, and substance 
misuse 
Strakowski et al., 1993; Kendler et al., 1993; Cassano 
et al., 1998. 
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Anxiety disorders  Boyd, 1986; Kendler et al., 1993; Cassano et al., 1998; 
Pokos & Castle, 2006. 
Eating disorders  Ferguson & Damluji, 1988; Andrew & Harris, 1994; 
Cassano et al., 1998. 
Intellectual disability Penrose, 1938; Turner, 1989; Doody et al., 1998; 
Hemmings, 2006; Morgan et al., 2008. 
Language disorders  DeLisi, 2001; Covington et al., 2005; Condray, 
Steinhauer & Goldstein, 1992; Condray, 2005. 
Neuropsychiatric 
disorders  
Takeuchi et al., 1986; Sverd, Montero & Gurevich, 
1993; Ståhlberg et al., 2004; Larsson et al., 2013. 
Obsessive-compulsive 
disorder 
Boyd, 1986; Cassano et al., 1998, Tibbo & Warneke, 
1999; Kayahan et al., 2005; Cederlöf et al., 2014. 
Personality disorders  Mueser et al., 1997; Moran & Hodgins, 2004. 
Somatic disorders  
Acute intermittent 
porphyria 
Propping, 1983; Cederlöf et al., 2015. 
Cardiovascular disease Baldwin, 1979; Hennekens et al., 2005. 
Chromosomal 
syndromes  
Murphy, Jones & Owen, 1999; Basset & Chow, 2008; 
Cederlöf et al., 2014. 
Metabolic syndrome Ryan & Thakore, 2002; McEvoy et al., 2005; Saari et 
al., 2005, de Hert al., 2013. 
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1.2.5 Consequences 
Schizophrenia is a life-shortening disorder; the mortality is approximately 
doubled and individuals with schizophrenia are eight times more likely to die 
from traumatic injuries than individuals without the disorder (Allebeck et al., 
1989). Furthermore, fitness is poor (Power et al., 2013), and it is well established 
that most individuals with schizophrenia experience a decline in social 
functioning already in the early stages of the disorder (Häfner et al., 1995). 
Moreover, many individuals with schizophrenia will develop an alcohol or 
substance misuse, even though these disorders may very well precede the onset 
of schizophrenia as well (Hambrecht & Häfner, 1996).  
The global functioning problems in individuals with psychosis is evidenced by 
the finding that, at least in Sweden, informal caregivers spend on average 22.5 
hours per week. Further, about 14% of their disposable incomes on activities 
related to care (Flyckt et al., 2011). About 5% of individuals with schizophrenia 
will eventually commit suicide (Palmer, Pankratz & Bostwick, 2005). 
1.3 OTHER PSYCHOTIC DISORDERS 
Outside of schizophrenia, there are several other forms of psychotic disorders in 
the DSM-5. If sorted by severity, the disorder regarded as second most severe 
after schizophrenia is schizoaffective disorder, because it also requires the 
presentation of multiple psychopathological domains.  
Two psychotic disorders are by definition limited to a single domain of 
psychopathology, namely catatonia, which is no longer considered a subtype of 
schizophrenia (as it was in the DSM-IV), and delusional disorder. Further, the 
DSM-5 defines two psychotic disorders based on duration of the psychotic 
episode; schizophreniform disorder, which is clinically very similar to 
schizophrenia but lasts for less than six months, and brief psychotic disorder, 
which may last between two days and one month. More, even though 
schizotypal personality disorder is part of the spectrum of schizophrenia, it is 
considered to lie below the diagnostic threshold for a psychotic disorder.  
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The “attenuated psychotic syndrome” which have been discussed extensively in 
the literature (e.g. Woods et al., 2010; Carpenter & van Os, 2014), apparently 
requires more research before it can be included in the main text as a new 
diagnosis in the DSM. 
1.4 BIPOLAR DISORDER 
The entity of bipolar disorder, originally called “circular madness”, was 
developed year 1851 by Falret (Angst & Sellaro, 2000), and the term “bipolar” 
was used first in 1957 (Philips & Kupfer, 2013). The lifetime prevalence of the 
most typical form of the disorder, i.e., type 1, is about 0.6% (Merikangas et al., 
2011). Due to its relatively early onset and the degree of chronicity, bipolar 
disorder is responsible for the loss of more disability-adjusted life years than for 
example all forms of cancer (WHO, 2002). The disorder is characterized by 
episodes of mania or hypomania, and depression, and it is currently divided into 
four main subtypes; type 1, which is characterized by severe depressive episodes 
and true manic episodes that may present with psychotic psychopathology and 
often require inpatient care; type 2, which is less severe than type 1 in all aspects, 
and very rarely include psychotic features; cyclothymic disorder, which is 
characterized by many hypomanic episodes and subclinical depressive 
symptoms, and lastly, bipolar disorder not otherwise specified, which include 
hypomania-like symptoms and depressive symptoms which do not meet 
diagnostic criteria for either hypomania or depression (Goodwin & Jamison, 
2007; Phillip & Kupfer, 2013). Hence, bipolar disorder is apparently a broad and 
heterogeneous diagnostic construct. 
1.4.1 Etiology and risk factors 
Twin studies, adoption studies, and family studies consistently report results in 
congruence with a strong genetic influence in the etiology of bipolar disorder. In 
a recent large family study based on Swedish nation-wide registers, the 
heritability was estimated to 58% (Song et al., 2014), which for some unknown 
reason is lower than the estimate of 85% generated from twin studies (Bienvenu, 
Davydow & Kendler, 2011). The reminder of the etiological influences in bipolar 
disorder is not well known, and there are very few established non-genetic risk 
factors, but Mortensen et al. (2003) have reported that early maternal loss 
increase the risk of later bipolar disorder, although possibly representing a 
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“genetically influenced” environmental risk. Other factors, such as traumatic 
brain injury and various stressful life events, have been suggested as risk factors, 
but available data is inconclusive and more research is clearly needed (Tsuchiya 
et al., 2003). 
In contrast to schizophrenia, very few studies have demonstrated premorbid 
neurodevelopmental aberrations in bipolar disorder, rather, some research 
indicates that adolescents with excellent school grades have elevated risks of later 
bipolar disorder, after adjusting for the potential effects of socioeconomic status 
and parental education (Maccabe et al., 2010). This finding is possibly restricted 
to males, although the interaction term between school grades and sex was not 
statistically significant in the study by MacCabe and colleagues. 
1.4.2 Correlates 
Just like in schizophrenia and most other psychiatric disorders, co-occurrence 
with other psychiatric disorder is the rule rather than the exception in bipolar 
disorder, even though the literature seem to be more limited than for 
schizophrenia. Some of the most commonly described psychiatric and somatic 
correlates are listed in table 1.4.2. 
 
Table 1.4.2. Frequently reported correlates of bipolar disorder. 
Correlate Reference 
Psychiatric disorders  
Alcohol, and substance 
misuse 
Cassano et al., 1998; McElroy et al., 2001; 
Merikangas et al., 2011; Song et al., 2014; Baethge et 
al., 2014; Simhandl et al., 2015. 
Anxiety disorders Cassano et al., 1998; McElroy et al., 2001; 
Merikangas et al., 2011; Song et al., 2014; O’Garro-
Moore et al., 2015. 
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Eating disorders McElroy et al., 2001; Krishna & Ranga, 2005; Lunde 
et al., 2009. 
Obsessive-compulsive 
disorder 
Kruger et al., 1995; Cassano et al., 1998; Angst et al., 
2005; Merikangas et al., 2011; Cederlöf et al., 2014. 
Neuropsychiatric 
disorder (e.g. ADHD) 
Ståhlberg et al., 2004; Krishna & Ranga, 2005; 
Merikangas et al., 2011; Larsson et al., 2013; Song et 
al., 2014. 
Personality disorders George et al., 2003; Krishna & Ranga, 2005; Song et 
al., 2014. 
Psychotic disorders Taylor, 1992; Laursen et al., 2009; Song et al., 2014. 
Somatic disorders  
Cardiovascular disease Baldwin, 1979; Goldstein et al., 2009; Westman et al., 
2013. 
Darier disease Craddock et al., 1994; Jones et al., 2001 
Multiple sclerosis Joffe et al., 1987; Krishna & Ranga, 2005; Carta et 
al., 2015. 
 
The correlation between bipolar disorder and Darier disease is of particular 
interest for this thesis and will therefore be described in more detail in 
subsequent sections.  
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 Darier disease 1.4.2.1
Darier disease (sometimes referred to as keratosis follicularis, dyskeratosis 
follicularis, or Darier-White disease) was first described by James C. White and 
Jean Darier in 1889 (White, 1889; Darier, 1889). It is a rare, autosomal 
dominantly inherited skin disorder caused by mutations within the ATPase, 
Ca++ transporting, cardiac muscle, slow twitch (ATP2A2) gene, which encodes 
a sarcoplasmic/endoplasmic reticulum calcium pump (SERCA2). SERCA2 
apparently plays key role for intracellular calcium signaling processes 
(Sakuntabhai et al., 1999).  
The estimated prevalence of Darier disease ranges from 1 in 100,000 individuals 
in Scandinavia, to 1 in 36,000 in north-east England (Burge, 1994). The onset of 
Darier disease is usually between ages ten and 20 years, but may occur as early as 
age six and as late as age 60 (Burge & Wilkinson, 1992). The disorder is 
characterized by multiple focal keratotic papules, mainly on the scalp and other 
seborrheic regions, nail changes and palmo-plantar pits, but the phenotype is 
highly variable, even though the penetrance is very high (Munro, 1992). Other 
symptoms include itch, pain, and malodor, which patients report as a particularly 
socially disabling and distressing problem. Heat, sweat, and for some patients, 
sunlight, exacerbates the disorder. Only about a third of individuals with Darier 
disease experience improvement with age (Burge & Wilkinson, 1992).  
The neuropsychiatric profile of Darier disease has received interest in the 
literature; in the earliest studies, several descriptions of mental problems 
reminiscent of intellectual disability crop up (Svendsen & Albrektsen, 1959; 
Getzler & Flint, 1966), and epilepsy seem to be overrepresented in the disorder 
(Burge, 1992). Psychotic episodes and schizophrenia-like syndromes have also 
been reported in a few cases (Medansky & Woloshin, 1961; Getzler & Flint, 
1966; Hellwig, Hesslinger & Waiden, 1996).  
About three decades after the first study in this field, researchers reported that 
Darier disease was exacerbated by lithium carbonate, the most classic 
psychotropic drug used for treatment of bipolar disorder (Clark, Hammer & 
Patterson, 1986; Milton et al., 1990). Subsequently, in an influential study, 
Craddock and colleagues (1994) found that Darier disease cosegregated perfectly 
with major affective disorder in an Irish family, meaning that all family members 
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with Darier disease also had a bipolar or depressive disorder, whereas none of 
the family members without Darier disease had bipolar disorder or major 
depressive disorder. This finding was later replicated in yet another Irish pedigree 
(Jones et al., 2001). 
There are at least three apparent possible explanations of the mechanism 
underlying the association between Darier disease and bipolar disorder (and 
schizophrenia). First, there is a possibility there is no true association between 
the disorders. This seems highly unlikely, however, given the numerous case 
reports suggesting otherwise, and the perfect cosegregation with major affective 
disorder.  
The seconds explanation can be described as follows; there is an association 
between Darier disease and bipolar disorder/schizophrenia in the general 
population. Theories surrounding this explanation posits that such an association 
could (hypothetically) occur either due to pleiotropic effects in the ATP2A2 
gene, i.e., that mutations in this particular gene increase the risk of both Darier 
disease and psychiatric disorder, or because the ATP2A2 is in “linkage 
disequilibrium” with some susceptibility gene for affective disorder, meaning 
that ATP2A2 is located very near the “true” susceptibility gene that produces 
liability to psychiatric disorder, and that these two genes are consequently 
inherited together. Supporters of the theory of pleiotropic effect have argued 
that because skin and brain tissues are both derived from the ectoderm, it can be 
hypothesized that a population association with psychiatric disorder is the result 
of a defect in cell adhesion expressed both in the skin and brain. This intriguing 
yet biologically plausible hypothesis was first proposed by Medansky & 
Woloshin (1961).  
Third, there is the possibility that social disability associated with Darier disease 
provoke “reactive” psychiatric illness in some patients, even though this seems 
unlikely, as Darier patients themselves do not attribute their psychiatric disorder 
to their skin disorder, and because the temporal order between disorder skin 
disorder and mental disorder is uncertain (Craddock et al., 1994). 
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1.4.3 Consequences 
The course of illness remains unfavorable for many individuals with bipolar 
disorder (Merikangas et al., 2011; Keck et al., 2014). Misuse of alcohol as well as 
illicit drugs is highly overrepresented (Strakowski et al., 2000), and as many as 
10% will eventually die from suicide (Goodwin & Jamison, 2007). Early age at 
onset of is associated with more comorbidity, more recurrences, and poor 
outcome (Perlis et al., 2004).  
1.4.4 Juvenile mania  
The disorder previously referred to as juvenile mania (Leibenluft et al., 2003) or 
pediatric bipolar disorder, is at the time of writing termed “disruptive mood 
dysregulation disorder” (DSM, 2013). Disruptive mood dysregulation disorder is 
one of few new diagnoses in the DSM-5, but the diagnosis clearly stems from 
prior descriptions juvenile mania and pediatric bipolar disorder (Pavuluri et al. 
2005), and was introduced as symptoms of mania/bipolar disorder in children 
are not regarded as sufficiently episodic to be defined as a bipolar disorder. 
(www.dsm5.org). The term juvenile mania will however be used from here on 
and throughout this thesis. The diagnostic criteria include irritability and frequent 
temper tantrums combined with persistent negative mood between these 
tantrums, and symptoms must have an onset before age ten, be present in 
multiple settings for at least one year, and should not be present before age six. 
The prevalence in the general population have been estimated to between 0.8% 
to 3.3% (Copeland et al., 2013; Pavuluri et al., 2005), and around 6% in clinical 
samples (Leibenluft & Rich, 2008).  
 Risk factors, correlates, and consequences 1.4.4.1
The etiology of juvenile mania is not well understood. Heritability estimates are 
lacking, but family studies suggest a genetic component, as it has been found that 
early-onset mania has a greater familial loading of adult-onset bipolar disorder 
(Neuman et al., 1997; Pavuluri et al., 2005).  
Only a few studies have examined longitudinal risk factors of juvenile mania or 
symptoms thereof. Whereas adult onset bipolar disorder is not, juvenile mania 
seems to be characterized by some developmental deficits, but the evidence is 
inconclusive; van Os et al (1997) and Sigurdsson et al., (1999) both reported 
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premorbid speech problems, whereas findings of Kutcher et al. (1998) indicate a 
perfectly normal premorbid functioning on language-related tasks. The origins of 
this discrepancy is difficult to assess, but may be related to the heterogeneity of 
individuals diagnosed with the disorder. 
Juvenile mania is highly comorbid with virtually any psychiatric disorder, 
especially depressive disorder, oppositional defiant disorder, anxiety disorder, 
conduct disorder and ADHD, but also substance misuse, psychotic disorder, 
language disorder, and antisocial personality disorder appear (Geller & Luby, 
1997; Biederman et al., 2005; Leibenluft & Rich, 2008; Copeland et al., 2013). 
Children with juvenile mania have excess risks of several adverse health 
outcomes, such as severely impaired psychosocial functioning (Biederman et al., 
2005), self-reported general poor health, sexually transmitted diseases, slow 
illness recovery, and tobacco use, but also criminal behaviors, police contacts, 
poverty, and poor educational attainment (Copeland et al., 2014).  
1.5 PSYCHOTIC EXPERIENCES 
There is a long-standing notion that psychotic phenomena exist in individuals 
with clinical presentations lying well below diagnostic thresholds (Kretschmer, 
1925; Meehl, 1962), and below prodromal psychosis (van Os et al., 2009). Such 
sub-/non-clinical psychotic symptoms are commonly referred to as psychotic 
experiences, but have also been called “psychotic-like experiences”, “psychosis-
like experiences, “psychosis proneness”, “at-risk mental state”, or in the earlier 
and more personality-based literature, “schizotypy”. Moreover, the influential 
American psychologist and psychometrician Paul Meehl used the term 
“schizotaxia” (Meehl, 1962).  
During the past decade, it has been demonstrated that these psychotic 
phenomena, who were once thought to be “the preserve of the asylum and 
classical psychiatry” (Murray & Jones, 2012, p.4), are common among 
adolescents in the general population: a meta-analysis have shown that psychotic 
experiences are reported by 7.5% of adolescents aged 13-18 years, and by 17% 
of adolescents aged 9-12 years (Kelleher et al., 2012a). As an anecdote, it is worth 
mentioning that these findings were initially regarded as incidental and 
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unexpected “byproducts” of epidemiological surveys targeting common 
psychiatric disorders such as depression (e.g. Kendler et al., 1996). 
Just as symptoms of clinical psychosis, psychotic experiences comprise auditory 
and visual hallucinations and delusions, but in contrast to frank disorder, 
psychotic experiences are most often accompanied with intact reality testing 
(Kelleher et al. 2013a). Most psychotic experiences seem to be transient, and 
persistent experiences have been proposed to be more clinically worrisome (van 
Os et al., 2009). In the same vein, the clinicopathological significance of 
psychotic experiences, i.e., the extent to which psychotic experiences are 
associated with psychopathology, increases with age during adolescence. 
(Kelleher et al., 2012b). 
1.5.1 Psychotic experiences in relation to a psychosis continuum, and 
an extended psychosis phenotype  
In the early and mid-stages of psychotic experiences research, these phenomena 
were thought to lie on a “psychosis continuum” (e.g. van Os et al., 2000; 
Verdoux & van Os, 2002). Actually, this idea was formulated first by Ernst 
Kretschmer, who postulated that “endogenous psychoses are nothing other than 
marked accentuations of normal types of temperament” (Kretschmer 1925, 
p.118). In this dimensional model, normality is apparently the reference point 
and psychotic experiences occur both in normality and in clinical psychosis. 
Thus, as put by the Dutch psychiatrist and researcher Jim van Os: 
 “Psychiatric morbidity in a population may be seen as a function of 
the degree to which the distribution of a continuous phenotype, 
measurable in both healthy and ill individuals, is shifted towards 
higher values” (van Os et al., 2009, p.179)”.  
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The validity of the psychosis continuum model is supported by for example the 
following observations: 
 There is a similar pattern of psychiatric comorbidity shared between 
individuals with psychotic experiences and individuals with 
schizophrenia (van Os et al., 2009). 
 There is a clear overlap in non-genetic risk factors of psychotic 
experiences and schizophrenia (van Os et al., 2009; Kelleher & Cannon, 
2011). 
 Psychotic experiences and schizophrenia are characterized by similar 
neurodevelopmental risk factors (Kelleher & Cannon, 2011). 
 The rates of psychotic experiences have been found to predict the rates 
of clinical schizophrenia in a Dutch population (van Os et al., 2001; van 
Os et al., 2009). 
 Psychotic experiences in childhood predict psychotic disorders in 
adolescence (e.g. Poulton et al., 2000). 
The psychosis continuum model became popular very quickly, most probably 
due to its moral appeal, its convergence with the orientation of modern 
psychiatric (and other health care) services, and because it reflects common 
clinical diagnostic uncertainties (David, 2010). However, Anthony David (2010) 
presented critique against the model, by noting that for example the distressing 
and hostile hallucinations that are typical for schizophrenia actually seem to 
never occur in general population individuals reporting psychotic experiences. 
Further, David (2010, p. 1940) argued that:  
“..seeing psychotic phenomena as a point on a continuum with 
‘normal’ experience is a useful heuristic with many positive benefits. 
However, like viewing a Necker cube, we can also consider the same 
phenomena with an eye on discontinuities and these may also 
provide points of theoretical growth. We should use methods and 
statistics that, rather than inevitably leading to continua (most 
psychometric methods in psychology and especially composite 
‘severity scales’), may also uncover potential categories”.  
 22 
The paper by David elicited an immediate response from Nick Kaymaz and Jim 
van Os (2010), who first argued that there is ample evidence for a psychometric 
psychosis continuum, but also for a latent categorical structure in the population, 
underlying this continuum. What they meant was that regardless of whether a 
continuum exist, the population may still be divided into two kinds of people; 
those with psychotic experiences and associated impairment and need for care, 
and those with psychotic experiences without these characteristics. Further, as 
the word “continuum” implies some specific theory, they suggested to instead 
refer to an extended psychosis phenotype.  
Even though several lines of evidence indicate that psychotic experiences are 
indeed part of an extended psychotic phenotype, it is also getting increasingly 
obvious that these phenomena probably are at least as correlated with other 
concurrent and future psychiatric disorders, such as anxiety disorders and 
depression, as with psychotic disorders.  
This notion has been elegantly formulated by Murray & Jones (2012, p. 5):  
“It appears that during adolescent development, a substantial 
minority of young people will have mild psychotic experiences just 
as they have individual symptoms of depression and anxiety from 
time to time. For most, these psychotic experiences will be 
transitory or, at worst, persist in a trait measured as schizotypy that 
will never deteriorate. Yet for a proportion of these individuals, the 
presence of psychotic and other symptoms heralds either 
concomitant or later psychiatric illness. Some adolescents and young 
adults manifest an eruption of mixed affective, psychotic and 
behavioural phenomena from which more specific blends of 
psychopathologies may emerge, some eventually crystalising 
syndromes familiar from the DSM and ICD.” 
Much remains to be learned about psychotic experiences in adolescence, but it is 
clear that they no longer can be viewed as specific predictors of later psychotic 
illness. Hence, psychotic experiences do not represent “schizophrenia light”, but 
may rather be driven by the severity of the concurrent non-psychotic symptoms, 
including affective symptoms (van Os, 2014). 
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1.5.2 Etiology and risk factors 
According to published data, genetic factors account for about 40 % of the 
liability to psychotic experiences (Polanczyk et al., 2010). In addition to this 
moderate genetic component, longitudinal studies have identified a vast array of 
risk factors. These longitudinal risk factors, i.e., processes or events that occur 
well before psychotic experiences, are outlined in alphabetical order in Table 
1.5.2. It should, however, be noted that the genetic and environmental 
contributions to the associations between these risk factors and later psychotic 
experiences rarely have been studied.  
 
 
Table 1.5.2. Longitudinal risk factors of psychotic experiences. 
Risk factor Reference 
Atopic disorder Khandaker et al., 2014b. 
Autistic traits Jones et al., 2012; Happé, 2012; Sullivan et al., 2014 
Cannabis use van Os et al., 2002; Henquet et al., 2004; Wiles et al., 
2006; Harley et al., 2010; Kounali et al., 2014. 
Epstein-Barr infection Khandaker et al., 2014c. 
Externalizing behavior 
problems 
Polanczyk et al., 2010; Kounali et al., 2014. 
Family history of 
psychiatric disorder 
Polanczyk et al., 2010. 
Harmful drinking or 
tobacco use 
Wiles et al., 2006. 
Internalizing behavior 
problems 
Wiles et al., 2006; Polanczyk et al., 2010; Kounali et 
al., 2014. 
Lower IQ Cannon et al., 2002; Horwood et al., 2008. 
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Maternal infection or 
obstetric complications 
Zammit et al., 2009 
Motor problems Kounali et al., 2014 
Night mares and terrors  Fisher et al., 2014; Thompson et al., 2015 . 
Physical maltreatment, or 
negative parenting 
Janssen et al., 2004; Kelleher et al., 2008; Polanczyk 
et al., 2010; Arseneault et al., 2014. 
Peer victimization Schreier et al., 2009; Harley et al., 2010; Kelleher et 
al., 2013b; Wolke et al., 2014; Arseneault et al., 2014; 
Kounali et al., 2014. 
Small for gestational age Polanczyk et al., 2010 
Speech, language, and 
mathematical problems 
Hameed et al., 2013; Khandaker et al., 2014a. 
 
Of particular interest for this thesis are the effects of childhood autistic traits, 
speech and language problems specifically, and neuropsychiatric problems in 
general. Therefore, these problems will be described briefly in the subsequent 
sections.  
 Language and mathematical problems 1.5.2.1
A disorder of language or mathematics denotes an “unexpected difficulty in one 
aspect of development that cannot readily be explained by such factors as low 
intelligence or sensorimotor impairment” (Pennington & Bishop, 2009, p.284). 
In study I, the not yet validated definitions of language and mathematical 
disorders are based on individual items from a parental screening interview. 
These definitions have uncertain clinical properties and therefore, the terms 
language and mathematical problems will used throughout the thesis.  
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Language problems may affect different levels and aspects of language, e.g. 
receptive language, syntax, semantics or pragmatics. Speech problems refer to 
difficulties with the production of speech sounds that has a negative impact on 
intelligibility, and reading problems involves difficulties with learning to read. 
Even though these problems are described as separate entities in diagnostic 
systems, comorbidity between these three types of problems are very common 
(Pennington & Bishop, 2009). Disorders of language and reading are prevalent in 
ca 3-10% of children and can have a serious impact on educational and 
psychosocial outcomes (Bishop & Snowling, 2004), but also behavioral 
outcomes such as hyperactivity and aggression (Beitchman et al., 1996), and 
psychiatric outcomes such as anxiety disorders (Beitchman et al, 2001). 
Symptoms of these disorders (i.e., problems with speech, language and reading) 
are even more prevalent (Hansson et al., 2005), but may still index risk of the 
development of clinical neuropsychiatric disorders and other adverse outcomes 
(Miniscalco et al., 2006). 
A clinical disorder of mathematics is often referred to as dyscalculia, although 
the literature is full of various terms, and has a prevalence of about 5-7% 
(Butterworth, Varma & Laurillard, 2011; Gross-Tsur, Manor & Shalev, 1996). 
Dyscalculia denotes severe difficulties with learning arithmetical skills, despite 
normal intelligence (Landerl, Bevan & Butterworth, 2004). As one would expect, 
the co-occurrence with other developmental disorders, such as dyslexia and 
ADHD, is considerable (Gross-Tsur, Manor & Shalev, 1996). Again, our 
definition of mathematical problems is not validated and relied on a single item, 
so the term mathematical problems will be used throughout this thesis. 
Longitudinal data is scarce, but mathematical problems seem to persist into 
adulthood (Shalev, Manor & Gross-Tsur, 2005). 
Using prospectively collected data from the ALSPAC birth cohort, Hameed and 
colleagues (2012) found that individuals reporting psychotic experiences in early 
adolescence were more likely to have had childhood deficits in reading and 
writing skills, such as spelling and non-word reading. These effects withstood 
after adjustment for socio-demographic variables. In the same vein, another 
ALSPAC cohort study (Khandaker et al., 2014) found that a composite score of 
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five childhood neurodevelopmental problems (dyslexia, dyspraxia, dysgraphia, 
dysorthographia, and dyscalculia) predicted adolescent psychotic experiences.  
 Autistic traits 1.5.2.2
The classification of autism spectrum disorder (ASD) relies on deficits in 
reciprocal social behavior, communication problems, and repetitive behaviors. 
Epidemiological, clinical and family studies have consistently suggested that 
symptoms of autism spectrum disorder, i.e., autistic traits, are dimensionally 
represented in the population (Constantino & Todd, 2000; Piven et al., 1997). 
Hence, the question whether ASD and autistic traits are different manifestations 
of the same underlying susceptibility or whether they have different etiologies 
has been raised by Lundström and colleagues (2012). They used data from the 
Child and Adolescent Twin Study in Sweden (CATSS) and found that cutoffs 
for ASD correlated strongly with the full variation of autistic traits, signifying an 
etiological link between categorical extreme-ends measures, and continuous 
measures of autistic phenomena. Further, through the use of twin modeling, the 
authors discerned that this correlation was predominantly explained by shared 
genetic influences. Similar results have been reported in other twin cohorts 
(Robinson et al., 2011). 
Again based on data from the ALSPAC cohort, three studies have demonstrated 
prospective associations between both parent-reported autistic traits and autism 
spectrum disorder in childhood on one hand and psychotic experiences in 
adolescence on the other (Jones et al., 2012; Sullivan et al., 2013; Happé, 2012). 
Jones and colleagues (2012) and Happé (2012) presented the first evidence of 
associations between autistic traits in general, and in particular speech problems, 
odd rituals and unusual habits, and psychotic experiences at age 12. Children 
whose mothers expressed concern over odd rituals at age 7-8 years had the most 
pronounced risks of later psychotic experiences. In another study it was found 
that children with autism spectrum disorder were three times more likely to have 
psychotic experiences at age 12 compared with children without autism 
spectrum disorder (Sullivan et al., 2013). 
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 General neuropsychiatric problems 1.5.2.3
Fairly recently, Pettersson and colleagues (2013) conducted a genetic factor 
analysis based on data from CATSS and demonstrated that one general (genetic) 
factor accounted for a substantial proportion (34%) of the covariation among 53 
symptoms of ASD, ADHD, tic disorder and learning disorder. In other words, 
this means that a general neuropsychiatric problems factor was responsible for 
the considerable phenotypic overlap between symptoms of neuropsychiatric 
disorders. Subsequently, it was found that this general neuropsychiatric factor 
was a better predictor of bully victimization than specific neuropsychiatric 
disorders, such as ADHD or autism spectrum disorder (Törn et al., 2015). 
1.5.3 Correlates 
Psychotic experiences may co-occur with virtually any adverse condition, 
characteristic or event, such as stress, alcohol dependence, poor educational 
qualifications (Johns et al., 2004), unemployment and relational problems (Scott 
et al., 2006; McGrath et al., 2015), low self-esteem and low optimism (Dolphin, 
Dooley & Fitzgerald, 2015), multi-morbid psychopathology, poor socio-
occupational functioning (Kelleher et al., 2014), low household income level 
(McGrath et al., 2015), and cognitive and motor deficits (Blanchard et al., 2010).  
1.5.4 Consequences 
A few studies have examined consequences of psychotic experiences. The by far 
most studied consequence is suicidal behavior and several studies have shown 
that psychotic experiences index risk of both concurrent and subsequent suicidal 
ideation (Nishida et al., 2010; Kelleher, Cederlöf & Lichtenstein, 2014; DeVylder 
et al., 2015; Lindgren et al., 2015) and suicide attempt (Kelleher et al., 2013a; 
DeVylder et al., 2015; Martin et al., 2015). The second most studied outcome is 
apparently psychotic disorder. In a seminal study based on the Dunedin 
Multidisciplinary Health and Development Study, Poulton and colleagues (2000) 
examined if self-reported psychotic experiences at age eleven predicted 
schizophreniform disorder at age 26. They found that children reporting 
psychotic experiences had a five to 15 times elevated odds of having a 
schizophreniform disorder at age 26, depending on whether the psychotic 
experiences were categorized as” weak” or “strong”. Similar results were 
reported 13 years later in a British cohort, where children with psychotic 
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experiences had six-to 13-times elevated odds of psychotic disorder at age 18, 
depending on whether psychotic experiences were categorized as “suspected” or 
“definite”. Other diagnostic outcomes have rarely been explored, but Dhossche 
et al. (2002) reported that self-reported auditory hallucinations at ages 11 to 18 
predicted depressive disorders and substance use disorders eight years later. 
The excess risks of substance misuse and suicidal behavior are especially relevant 
for this thesis, so these phenomena will be described briefly below. 
 Alcohol and substance misuse 1.5.4.1
The classifications of alcohol and substance misuse (hereafter referred to as drug 
use disorder) have undergone many changes over the years. In the DSM-5, 
which no longer separates diagnoses of misuse and dependence, at least two out 
of eleven diagnostic criteria covering aspects of problematic use need to be 
fulfilled in order for an individual to be diagnosed with a drug use disorder(APA, 
2013). The prevalences of drug use disorders have been estimated to between 6 
and 10% (Rehm et al., 2005; Merikangas et al., 2010). Heritability estimates vary 
considerably across different types of drugs and samples, but genetic effects 
seem to typically account for at least 30% of the liability (Ball & Collier, 2002).  
 Suicidal behavior 1.5.4.2
Suicidal behavior is a major cause of death and injury and an enormous public 
health problem worldwide. Whereas completed suicide is more common among 
men, non-fatal suicidal behaviors are more prevalent in women, young persons, 
and individuals with psychiatric disorders. There is a significant genetic 
component in the etiology of suicidal behavior, accounting for about 45% of the 
liability (Statham et al., 1998), but stressful life events, such as romantic 
skirmishes, family conflicts, and legal problems, are also important risk factors 
(Nock et al., 2008).  
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Suicidal behavior can be conceptualized as a “ladder” of thoughts and behaviors 
starting with self-harm with unclear intent at the bottom and ending with 
completed suicide at the top: 
 Completed suicide 
 Suicide attempt 
 Preparatory acts toward suicidal behavior 
 Suicidal ideation 
 Self-harming behavior without intent to die 
 Non-deliberate self-harm 
 Self-harm behavior with unclear suicidal intent 
1.5.5 Auditory hallucinations versus other psychotic experiences 
Several lines of evidence have shown that auditory hallucinations are the most 
important psychotic experiences. First, Dhossche and colleagues (2002) 
demonstrated that adolescents reported auditory hallucinations, but not visual 
hallucinations, had elevated risks of developing a clinical psychiatric disorder at 
follow-up, compared with controls. Furthermore, in two studies, it has been 
found that among psychotic experiences, auditory hallucinations has the highest 
positive predictive values when compared with clinically verifiable auditory 
hallucinations as well as other psychotic experiences (Horwood et al., 2008; 
Kelleher et al., 2011a). Moreover, in a Dutch general population sample, auditory 
hallucinations, but not visual hallucinations or delusions, predicted need for 
psychiatric care (Bak et al., 2005). Finally, Welham et al. (2010) reported that 
auditory hallucinations were better predictors of adult psychotic disorder than 
visual hallucinations and delusions. Based on these findings, we analyzed 
auditory hallucinations separately from the other psychotic experiences (i.e., 
visual hallucinations and delusions) in study I, II and IV.  
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2 AIMS 
The aims of this thesis were to examine the neurodevelopmental origins of 
adolescent psychotic experiences, to investigate a possible population association 
between Darier disease and schizophrenia/bipolar disorder, and to examine 
consequences of adolescent psychotic experiences, namely drug use disorder and 
suicide attempt. Where possible, the extent to which genetic and environmental 
factors influenced the associations was also examined. In more detail, the 
specific research questions addressed in the four studies were as follows: 
Study I: 
Are childhood problems with language and mathematics associated with 
adolescent psychotic experiences or juvenile mania symptoms? What are the 
relative contributions of genetic and environmental factors in these associations? 
Study II:  
Can the alleged association between autistic traits in childhood and adolescent 
psychotic experiences rather be explained by general neuropsychiatric problems? 
If so, to what extent is this association influenced by genetic and environmental 
factors? 
Study III:  
Is there an association between Darier disease and schizophrenia/bipolar 
disorder  in the general population? 
Study IV:  
Are adolescent psychotic experiences associated with later drug use disorder or 
suicide attempt? 
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3 MATERIALS AND METHODS 
3.1 DATA SOURCES 
3.1.1 The Swedish Twin Register 
The Swedish Twin Registry (STR) was established in the 1950s. With its almost 
200.000 members, out of which more than 150.000 have determined zygosity, it 
is the largest twin register in the world. The STR was established in the 1950s, 
and since then, it as has been an significant resource for large-scale studies of the 
genetic and environmental contributions to a wide range of traits and diseases 
(Magnusson et al., 2013). It is also possible to link data from the STR to national 
registers. 
3.1.2 The Child and Adolescent Twin Study in Sweden (CATSS) 
CATSS is a longitudinal study targeting all twins born in Sweden since the 1st of 
July 1992 (Anckarsäter et al., 2011). The study was launched in 2004 and is 
structured in three waves: CATSS-9/12, CATSS-15, and CATSS-18. In CATSS-
9/12, parents of twins (identified via the Swedish Twin Register) are interviewed 
by lay interviewers over the telephone about their children’s health and 
development, including an assessment of a range of neuropsychiatric problems 
(see section 3.2.1). This interview is conducted in connection with the children’s 
ninth birthdays, but in the first three years of the study, 12-year old twins were 
also included. These ages were chosen because most child psychiatric conditions 
and very few adolescent psychiatric conditions are established by then 
(Anckarsäter et al., 2011).  
In the CATSS-15 and CATSS-18 studies, both twins and their parents are 
contacted and asked to fill out separate questionnaires targeting mental, somatic 
and social health, including psychotic experiences and symptoms of juvenile 
mania. The CATSS was designed to establish a nationwide twin study 
appropriate for large scale epidemiological research, and is now the most 
comprehensive twin study on childhood and adolescent health problems in the 
world, including 27,500 members at the time of writing. Study participants 
provided informed consent and were repeatedly given the opportunity to 
discontinue their participation in the studies. 
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3.1.3 Swedish National Registers 
Sweden collects nationwide registry data since 1749 (Ludvigsson et al., 2009), 
and residents have been given a unique personal identification number 
(personnummer) since 1947, either at birth or at their immigration to the 
country. The number is used by governmental agencies in their data collection. 
Statistics Sweden is the governmental agency that is responsible for organizing 
such data into registers. The personnummer thus enables Statistics Sweden to 
generate data sets that include data provided by multiple agencies. Researchers at 
Swedish universities are entitled to use de-identified data (i.e., data without the 
personnummer) in research following approval from an ethical review board. 
The following registers were used in this thesis: 
 The Multi-Generation Register (MGR). The MGR enables linkage of 
index persons in the Total Population Register to their biological (and 
adoptive) parents. The coverage of data for maternal kinships is 
complete for individuals born in Sweden since 1950, whereas individuals 
born in Sweden before? 1950 can be linked to their mothers, and for 98 
percent of the individuals also to their fathers (Statistics Sweden, 2013). 
 The Total Population Register (TPR). This register was established in 
1967 and is held by Statistics Sweden. The TPR contains demographic 
data such as sex, birth date, country of birth, dates of migration, and 
residential address, for all Swedish residents born after 1932. 
 The Small Area Marketing Statistics (SAMS) Register. The SAMS register 
is a geographical classification system comprising more than 9,000 
residential areas. SAMS is provides a definition of residential areas based 
on the local housing distribution. Since 1982, Statistics Sweden has 
assigned Swedish residents to SAMS areas based on their registered 
residential address annually (Statistics Sweden, 2005). 
 The National Patient Register (NPR). The NPR is held by the National 
Board of Health and Welfare and contains diagnosis codes classified 
according to the World Health Organization’s International 
Classification of Diseases; ICD-8 (1969 to 1986), ICD-9 (1987 to 1996) 
and ICD-10 (1997 to 2009), and data concerning admission and 
discharge for all psychiatric inpatient episodes since 1973. Diagnoses 
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are assigned by the treating medical doctor upon discharge from the 
hospital. Data on outpatient specialist care is available from year 2001, 
albeit with incomplete coverage before 2006. 
3.2 MEASURES 
3.2.1 The Autism-Tics AD/HD and other Comorbidities inventory 
(A-TAC) 
The A-TAC is a comprehensive parental telephone interview developed by 
researchers at the Department of Child and Adolescent Psychiatry at the 
University of Gothenburg. The A-TAC is designed to be used in large-scale 
epidemiological settings to screen general populations for mental health 
problems. The A-TAC covers all major clinical diagnoses in child and adolescent 
psychiatry listed in the DSM-IV, i.e., autism spectrum disorder, ADHD, tic 
disorder, developmental coordination disorder and learning disorders (APA, 
1994), as well as additional items targeting other psychiatric disorders (Hansson 
et al., 2005). The items in A-TAC are formulated to reflect symptom criteria 
according to the DSM-IV (APA, 1994), as well as clinical features. In addition, 
the A-TAC also assesses age of onset and dysfunction and suffering.  
A-TAC is structured into 19 modules corresponding to diagnoses (e.g., 
concentration & attention, impulsiveness & activity (which together constitutes 
the ADHD domain), social interaction, language, flexibility (constitutes the ASD 
domain) that are assessed dimensionally not adhering to mutually exclusive 
criteria. The questions are asked in a lifetime perspective, in comparison with 
peers and allows four response categories; ‘yes’ (scored 1), ‘yes, to some extent’ 
(scored 0.5), ‘no’ (scored 0) , and ‘do not know/do not wish to answer’ (both 
scored as missing).  
Initially the A-TAC consisted of 178 symptom questions and the first validation 
study compared results of children who were on the waiting list for a 
neuropsychiatric assessment with the results of controls (Hansson et al., 2005). 
The inter-rater agreements were excellent (<0.90) and test re-test reliability in the 
good to excellent range (<0.70). Diagnoses of autism spectrum disorder and 
ADHD could be predicted with excellent sensitivity and specificity, and other 
diagnoses with moderate to good classifications. In the pilot study of the 
CATSS, the A-TAC contained 227 symptom questions which were 
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systematically reduced. The interview was organized into a “gate structure”, 
where all parents were asked the “gate questions” and only those who endorsed 
any of the gate questions were asked more detailed questions. 
In a second validation study of the A-TAC, children on the waiting list for 
neuropsychiatric assessment were compared with children whose parents had 
participated in the CATSS (Larson et al., 2010). Different scores were then 
tested against clinical diagnoses (when eligible), and the previously reported 
properties (Hansson et al., 2005) were replicated and could be maintained using 
96 gate questions items only. Thus, the final version of the A-TAC consisted of 
96 symptom questions in addition to the items assessing age of onset as well as 
dysfunction and suffering. Furthermore, the A-TAC has been validated in a 
prospectively fashion where twins screen positive for neurodevelopmental 
disorders, and screen-negative controls, where invited to participate in a clinical 
interview three years after the A-TAC interview (Larson et al., 2013). Sensitivities 
and specificities for the clinical diagnoses ranged from good-excellent and 
confirmed that the A-TAC has an excellent ability to separate ‘cases’ from 
‘controls’ in longitudinal studies. Two doctoral theses have been published 
concerning the validity and reliability of the A-TAC (Larson, 2013; Hansson, 
2015). Although the structure of the A-TAC has changed throughout the 
CATSS, the questions used in this thesis has been present since the beginning. 
The A-TAC can be freely downloaded from www.childnps.se.  
3.2.2 Language and mathematical problems 
For purposes of study I, a scale of communication problems was constructed by 
adding four items targeting problems with conversations and voice use from the 
ASD module in the A-TAC. A cut-off of 0.5 scores was applied, which 
generated a prevalence of 13%. Problems with speech, reading, and mathematics 
were defined using one item each targeting delayed speech, reading, and 
mathematical development, respectively. For speech problems (prevalence 9%) 
and mathematical problems (prevalence 13%) a cutoff of 0.5 was used, whereas 
the cut-off for reading problems (prevalence 7%) was set to 1. 
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3.2.3 Autistic traits 
A continuous scale of autistic traits was used in study II. This scale was created 
by adding all 17 items targeting different aspects of autism spectrum disorder in 
the relevant A-TAC modules. 
3.2.4 General neuropsychiatric problems 
A general neuropsychiatric problems factor comprising a total of 53 symptoms 
of ADHD, tic disorder, learning disorder and developmental coordination 
disorder was extracted from the A-TAC and used in study II. The factor was 
defined according to Pettersson and colleagues (2013) recent paper.  
3.2.5 Psychotic experiences 
Self-and parent-reported psychotic experiences were outcome measures in 
studies I and II, and exposure measure in study IV. The total of seven items in 
the CATSS-15 and CATSS-18 data collections have been used previously in 
community-based research (e.g. Poulton et al., 2000) and correspond very closely 
to the Adolescent Psychotic-Like Symptom Screener (Kelleher et al., 2011a). The 
individual items are listed below: 
 Sometimes I thought that I was being followed or spied upon. 
 Other people have read my thoughts. 
 Sometimes I have thought that I was being sent special messages 
through the television. 
 I have special powers that other people don't have. 
 Sometimes I felt that I was under the control of some special power. 
 Sometimes I have seen something or someone that other people couldn't 
see. 
 Sometimes I have heard voices other people couldn't hear. 
In study I and II, auditory hallucinations were analyzed separately from the other 
psychotic experiences, and self-reports were separated from parent-reports in all 
studies. Scales of self-reported (range 0-7) and parent-reported (range 0-14) 
other psychotic experiences in the CATSS-15 data collection were created and 
used in study I and IV (only self-reported). The analyses in study II and IV 
concerned self-reported psychotic experiences only. 
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3.2.6 Juvenile mania symptoms 
Scales of self-reported and parent-reported juvenile mania symptoms were 
created for purposes of study I. These scales comprised nine items from The 
Child Mania Rating Scale Brief Version (Henry et al., 2008) targeting problems 
with irritability, temper tantrums, and grandiosity during the last month. All nine 
items are introduced with “Does it happen that you..” and are listed below. 
 Have periods of feeling super happy for hours or days at a time, 
extremely wound up and excited, such as feeling “on top of the 
world”. 
 Feel irritable, cranky, or mad for hours or days at a time. 
 Believe that I have unrealistic abilities or powers that are unusual, 
and may try to act upon them, which causes trouble. 
 Need less sleep than usual; yet do not feel tired the next day. 
 Have periods of too much energy. 
 Have periods of racing thoughts that my mind cannot slow down , 
and it seems that my mouth cannot keep up with my mind. 
 Talk so fast that I jump from topic to topic. 
 Behave in a sexually inappropriate way (e.g., talks dirty, exposing, 
playing with private parts, masturbating, making sex phone calls, 
humping on dogs, playing sex games, touches others sexually). 
 Have rage attacks, intense and prolonged temper tantrums. 
Similarly as for psychotic experiences, self-reports and parent-reports were 
separated in the analyses. In study I, scales of self-reported (ranges 0-27 and 0-8, 
respectively) and parent-reported (ranges 0-27 and 0-8, respectively) juvenile 
mania symptoms in CATSS-15 and CATSS-18 studies were used. 
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3.2.7 Darier disease 
Darier disease was defined as at least one diagnosis of 757D (ICD-9) or Q82.8E 
(ICD-10). Owing to the poor specificity of the ICD-8 code for Darier disease, 
which includes several other congenital malformations of skin, this particular 
code was excluded. 
3.2.8 Schizophrenia and bipolar disorder 
Schizophrenia was defined as at least one inpatient episode in the NPR 
according to the following diagnosis codes: 295.0-295.6 (ICD-8), 295A-295G 
(ICD-9), F20 (ICD-10).  
Bipolar disorder was defined according to a validated algorithm (Sellgren et al., 
2011) including the following diagnosis codes: 296 (ICD-8, ICD-9), F30, F31 
(ICD-10), excluding those whose diagnoses relied only on 296.2 or 296B. This 
definition relies on at least two discharge diagnoses in the NPR. 
Diagnoses of chronic or severe disorders in the NPR are generally valid 
(Ludvigsson et al., 2011), and the diagnosis codes for schizophrenia and bipolar 
disorder have more than 90% agreement when compared with research 
diagnoses (Ekholm et al., 2005; Sellgren et al., 2011). The definition by Ekholm 
and colleagues is based on two discharge diagnoses in the NPR, but due to issues 
pertaining to statistical power, the definition used in study III relied on one 
diagnosis instead of two. However, extensive sensitivity analyses using one vs. 
two diagnoses have failed to reveal any meaningful differences in other nation-
wide Swedish studies (Sariaslan et al., 2015). A recently published validation 
study showed the same pattern in Danish register data (Sörensen et al., 2015).  
3.2.9 Drug use disorder 
Drug use disorder was defined as an inpatient or outpatient diagnosis of F10-
F16, and F18-F19 in the ICD-10. 
3.2.10 Suicide attempt 
A suicide attempt was defined as at least one inpatient or outpatient ICD-10 
diagnosis of X60-X84, or Y10-Y34. 
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3.3 STUDY DESIGNS 
3.3.1 Prospective cohort study 
Studies I, II, and IV are all prospective cohort studies. A cohort can be defined 
as a group of individuals who share some characteristics and are followed up 
over some period of time. Individuals at risk is typically defined according to 
their status on a given exposure (risk factor) and followed-up with the aim of 
comparing their outcome status with individuals with a different status with 
regards to the exposure. The word prospective means that the outcome status is 
unknown at baseline and that the study “peaks into the future”, in contrast to 
retrospective studies. When follow-up is completed, relative risks can be 
estimated by comparing the outcome status in the exposed vs. unexposed group, 
typically involving some kind of regression modeling (Rothman, 2002). 
3.3.2 Matched cohort study 
Study III is a matched cohort study, and in this study design, unexposed subjects 
are matched to exposed subjects on a set of potential confounders such as age, 
sex and residential area. Matched cohort studies are getting increasingly popular 
and are useful for researchers with access to large population data sets with 
information about potential confounders (Sjölander et al., 2012). For example, a 
cohort matched 1:10 contains pairs of observations (1 exposed and 10 
unexposed subjects) with the same level of the matching variables, typically the 
same sex and age. The exposed subjects are identified first, and unexposed 
subjects are subsequently matched with randomly selected unexposed subjects. 
Thus, the matching scheme in matched cohort studies is by definition 
completely “exposure driven” (Sjölander et al., 2012, p.4). The statistical analyses 
in matched cohort studies usually involve conditional logistic regression models. 
3.3.3 Family study 
In addition to being a matched cohort study, study III is also a (matched) family 
study. They key assumption that family studies rely on is that similarity is greater 
within families than between families. Family studies are commonly used to 
examine the “phenotypic signal” and the familial, i.e., genetic and shared 
environmental, causes of comorbidity between two disorders. The extent of 
shared pathophysiology can then be estimated by comparing the occurrence of 
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the comorbid disorder in relatives of individuals with only the index disorder and 
not the comorbidity, versus in unaffected relatives to matched comparison 
individuals without the index disorder. (Szatmari, White & Merikangas, 2007).  
The rationale for the use of the family study method in study III was based on 
the fact that if the occurrence of the comorbid disorder (i.e., schizophrenia or 
bipolar disorder) is increased only when coupled with the index disorder (Darier 
disease), this would suggest that the index disorder promotes the comorbid 
disorder (Merikangas, 1990).  
3.4 STATISTICAL ANALYSES 
3.4.1 Logistic regression 
Logistic regression analyses are widely used in epidemiological research. Such 
analyses describe the association between a categorical (binary or ordinal) 
outcome and one or more predictor variables (categorical or continuous). The 
output from logistic regressions are odds ratios (OR), which denotes the 
probability of having the outcome divided by the probability of not having the 
outcome if you are in the exposed group, compared with the probability of 
having the outcome, divided by the probability of not having the outcome if you 
are in the unexposed group. If the outcome is rare, the OR can be regarded as a 
risk ratio. In situations where controls (in case-control studies) or unexposed 
subjects (in cohort studies) are individually matched to cases or exposed subjects, 
i.e., stratified data as in study III, the conditional logistic regression model is 
preferred (Rothman, 2002). Logistic regression models are used in study I, and 
conditional logistic regression models are used in study III. 
3.4.2 Cox regression 
The Cox regression model is a model often used in epidemiological follow-up 
studies, as it enables modeling of survival data. Survival models such as the Cox 
regression aim to measure the risk of an event but also the quantity of time it 
takes for the event to happen. Importantly, survival models also take right 
censoring, i.e., that study participants exit the study before the event occur or 
before the end of the follow-up, into account. The model estimates relative 
hazard rates and the magnitude of the effects are stated as hazard ratios (HR). 
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An assumption of the Cox regression model is that the hazard rates are 
proportional (Cleves, 2008). A Cox regression model is used in study IV. 
3.4.3 Twin modeling 
Twin models are used in studies I and II. The extent to which a trait is 
influenced by genetic factors, the phenotypic similarity correlates with the degree 
of genetic relatedness. Using monozygotic (MZ; who are genetically identical) 
and dizygotic (DZ; who share in average 50% of their segregating genes) twins, 
this principle can be used to estimate the relative contribution of genetic and 
environmental factors in the variation or covariation of one or more traits. Thus, 
the existence of these two types of twin pairs with differing genetic relatedness 
provides a powerful “natural experiment” for unraveling genetic from 
environmental factors in a given trait or for associations (Rijsdisjk & Sham, 2002; 
Verweij et al., 2012).  
It is possible to partition trait variation into three source, or components: A, 
which denotes additive genetic factors, i.e., the sum of all influencing genes, C, 
which denotes shared environmental factors (factors shared between family 
members), and E, which denotes unique environmental factors (factors not 
shared between members of a family). The E component also includes 
measurement errors. The total (phenotypic) variation in a trait is the sum of 
these variance components (A+C+E). Given that 100% of the variation in a trait 
is due to variation in genetics, a correlation of 1 for MZ twin pairs and 0.5 for 
DZ twin pairs would be expected.  
Hypothetically, because both MZ and DZ twin pairs share environmental 
influences, we would expect a correlation of 1 for both types of pairs if the C 
component was the only source of variation in a trait. Furthermore, unique 
environmental influences (E) are not shared between individuals, so if the 
variance in a trait was solely influenced by E, a correlation of 0 would be 
expected for both MZ and DZ pairs. The MZ twin pair correlation can thus be 
summarized as A + C, and the DZ twin pair correlation as 0.5A + C. By using 
the formulas below, it is thus possible to estimate the proportion of variation 
that is influenced by A, C and E, using observed phenotypic correlations for MZ 
(
r
MZ) and DZ (
r
DZ) twin pair correlations.  
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Formulas solving for the A and C components: 
r
MZ = A + C. 
r
DZ = 0.5A + C. 
A = 2 (
r
MZ-
r
DZ), commonly referred to as ”Falconer´s formula”. 
C = 2 
r
DZ-
r
MZ.  
We know that A + C + E equals 1, so E must be equal to 1 - 
r
MZ.  
Rather than using these formulas for calculation of the A, C and E components, 
structural equation modeling is generally employed to generate more precise 
estimates, including corresponding confidence intervals. In Figure 3.4.3, the 
classic twin model is depicted as a path diagram. 
Figure 3.4.3 Path diagram of the classical twin model. 
 
 
 
In this model, P1 and P2 refer to the observed phenotype of twin 1 and 2 in a 
pair, for example auditory hallucinations as in study I. The circles refer to the 
variance components that measure the contributions of A (additive genetics), C 
(shared environments), and E (unique environments) to the studied phenotype. 
The standardized regression coefficients (lowercase a, c, and e) mirror the 
magnitude of the associations between the variance components and the 
phenotypes. 
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This basic univariate model can relatively easily be extended to include two (or 
more) traits, in order to partition the covariance between two traits. Hence, 
bivariate models can be used to answer questions like “to what extent is the 
correlation between height and weight due to overlapping genetic and/or 
environmental factors?”. An example of a bivariate twin model is illustrated in 
Figure 3.4.4. 
Figure 3.4.4. The bivariate twin model as a path diagram.
 
Here, Q1 and Q2 refer to the observed phenotypes for one of the twins in a 
pair. For example, C1 is a latent shared environmental factor that influences 
both measured phenotypes, and A2 is a latent shared environmental factor that 
influences only phenotype 2. The same structure applies for the A and E factors. 
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4 STUDY SUMMARIES AND RESULTS 
4.1 STUDY I – LANGUAGE PROBLEMS AND LATER 
PSYCHOTIC EXPERIENCES, AND JUVENILE MANIA 
SYMPTOMS 
Study I is a prospective cohort study based on data from the CATSS-9/12, 
CATSS-15, and CATSS-18 studies. The sample comprised 5,812 twins and one 
of their parents (their mother where possible). The main aim of this study was to 
examine if children with language or mathematical problems in childhood, 
assessed in CATSS-9/12 with the A-TAC, would have elevated risks of having 
self-reported or parent-reported psychotic experiences in adolescence (assessed 
in the CATSS-15 and 18 studies) after adjusting for a set of possible 
demographic confounders. Risks of juvenile mania symptoms were also 
estimated in the same children. Based on the literature suggesting important 
differences between auditory hallucinations and other psychotic experiences (see 
section 1.5.5), we analyzed auditory hallucinations separately from the other 
psychotic experiences, i.e., visual hallucinations and delusions. Associations were 
examined with logistic regression models. As statistically dependent twin pairs 
were used in the analyses, a robust sandwich estimator was used to adjust for the 
correlated data when calculating the confidence intervals. In addition, we 
examined the genetic and environmental contributions to the possible 
associations, using bivariate twin analyses based on structural equation modeling.  
4.1.1 Results 
After adjusting for demographic factors, the most consistent finding was that 
children with communication problems had elevated risks of having auditory 
hallucinations at ages 15 and 18 years (self-reported), other psychotic experiences 
at age 15 (self-and parent-reported), and juvenile mania symptoms at ages 15 and 
18 (parent-reported). Further, reading problems also predicted psychotic 
experiences and mathematical problems predicted juvenile mania symptoms 
(Table 4.1.1). In the analyses concerning psychotic experiences, statistically 
significant odds ratios ranged from 1.3 to 7.3, and associations were generally 
more prominent between childhood language and mathematical problems and 
auditory hallucinations than between childhood problems and the scale of other 
psychotic experiences. 
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Table 4.1.1. Associations between childhood problems and later adolescent auditory 
hallucinations, other psychotic experiences (PE), and juvenile mania symptoms. 
Significant associations are denoted with a X. 
 Auditory hallucinations Other PE Juvenile mania symptoms 
 Age 15 Age 18 Age 15 Age 15 Age 18 
Rater Child Parent Child Parent Child Parent Child Parent Child Parent 
Communication 
problems 
X  X  X X  X  X 
Reading 
problems 
   X       
Mathematical 
problems 
       X  X 
Speech 
problems 
          
 
Due to insufficient statistical power and/or distributional problems, bivariate 
twin analyses were employed only on the associations between communication 
problems and self-reported auditory hallucinations, parent-reported other 
psychotic experiences, and parent-reported juvenile mania symptoms at age 15 
years. 
These analyses revealed that genetic effects explained essentially the entire 
association between communication problems and the studied adolescent 
psychiatric symptoms, whereas unique environmental effects where non-
significant and of considerably less importance (Figure 4.1.1). 
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Figure 4.1.1. Genetic and environmental contributions to the associations 
between childhood communication problems and adolescent auditory 
hallucinations, other psychotic experiences, and juvenile mania symptoms. The 
Y axis shows phenotypic correlations. The shades of the graphs indicate the 
proportion of the phenotypic associations explained by genetic and 
environmental effects, respectively.
 
 Note: auditory hall. = auditory hallucinations, other PEs = other psychotic experiences. 
 
4.2 STUDY II – GENERAL NEUROPSYCHIATRIC PROBLEMS, 
AUTISTIC TRAITS, AND LATER PSYCHOTIC 
EXPERIENCES 
This prospective cohort study was based on 9,282 twins who were members of 
the CATSS-9/12 and the CATSS-15 and/or the CATSS-18 studies. Here, we 
examined if the alleged association between autistic traits in childhood and self-
reported psychotic experiences in adolescence would rather be explained by a 
general neuropsychiatric problems factor, comprising symptoms of ADHD, tic 
disorder, developmental coordination disorder and learning disorder. Both 
autistic traits and general neuropsychiatric problems were assessed with the A-
TAC in the CATSS-9/12 study. First, auditory hallucinations were regressed on 
autistic traits. Second, the general neuropsychiatric problems factor was added to 
the model. We also disentangled the genetic from environmental influences in 
the associations. As in study I, auditory hallucinations were analyzed separately 
from the other psychotic experiences, which were further divided into visual 
hallucinations and delusions.  
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4.2.1 Results 
Replicating prior studies, associations were found between childhood autistic 
traits and adolescent psychotic experiences at ages 15 and 18 years, but only for 
auditory and visual hallucinations (Table 4.2.1, crude model). Beta coefficients 
were moderate and ranged from 0.05 to 0.09. When the general neuropsychiatric 
problems factor was included in the model, all significant associations in the 
univariate model disappeared (Table 4.2.1, full model). However, the association 
between the general neuropsychiatric problems factor and auditory (but not 
visual) hallucinations remained after adjustment for the effect of autistic traits 
(Table 4.2.1, full model). 
 
Table 4.2.1. Crude and adjusted associations between childhood autistic 
traits, a general neuropsychiatric problems factor, and adolescent 
hallucinations. Associations are expressed as β coefficients and 95% 
confidence intervals (CI).  
 Crude model Full model 
 Exposure Exposures 
 Autistic traits Autistic traits General 
neuropsychiatric 
problems factor 
Outcomes β (CI) β (CI) β (CI) 
Age 15 auditory 
hallucinations 
0.07 (0.03-
0.11) 
-0.08 (-0.18- 
0.02) 
0.24 (0.10- 
0.38) 
Age 18 auditory 
hallucinations 
0.09 (0.05-
0.13) 
-0.04 (-0.16- 
0.10) 
0.21 (0.03- 
0.39) 
Age 15 visual 
hallucinations 
0.05 (0.02-
0.10) 
-0.01 (-0.08- 
0.06) 
0.10 (-0.01- 
0.20) 
Age 18 visual 
hallucinations 
0.07  (0.01-
0.13) 
0.01 (-0.13- 
0.15) 
0.11 (-0.11- 
0.32) 
Note: statistically significant associations are shown in bold.  
 
We continued with twin modeling on the association between the general 
neuropsychiatric factor and auditory hallucinations, i.e., the significant 
associations in the full model presented in Table 4.2.1. To increase statistical 
power, a latent factor comprising auditory hallucinations at both ages was used, 
as these two variables correlated highly (r =0.64). The results from these twin 
analyses are illustrated in Figure 4.2.1. It was found that the association 
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between the general neuropsychiatric problems factor and auditory 
hallucinations was influenced in essence only by genetic factors, whereas 
influences from unique environmental factors were negligible.  
Figure 4.2.1. Standardized regression weights for genetic and unique 
environmental components of the association between a general 
neuropsychiatric problems factor, and auditory hallucinations at ages 15/18. 
 
Note: DCD = developmental coordination disorder, LD = earning disorder, AT = autistic 
traits, TD = tic disorder. A = additive genetic factor, E = unique environmental factor. The 
bolded line denotes p<0.05, and the dotted line denotes p>0.05. 
4.3 STUDY III – DARIER DISEASE AND SCHIZOPHRENIA, 
AND BIPOLAR DISORDER 
In this matched cohort study and family study, we used data from the National 
Registers to investigate if individuals with Darier disease (n=788), or their first-
degree relatives (n=3,288), would have an increased risk of being diagnosed with 
schizophrenia or bipolar disorder compared with matched comparison 
individuals (ratio 1:10). Matching criteria were age, sex and county of residence 
for the analyses concerning individuals with Darier disease, and age and sex for 
the analyses concerning relatives to individuals with Darier disease. Associations 
were examined with conditional logistic regression models.  
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When assessing shared familial risks between two disorders, a common method 
is to exclude relatives who have the index disorder, i.e., Darier disease, 
themselves. Therefore, we conducted an additional analyses specified accordingly 
and expected that the associations to schizophrenia and bipolar disorder would 
disappear, due to the virtually complete penetrance of the Darier-causing 
mutations. 
4.3.1 Results 
Results from the conditional logistic regressions showed that individuals with 
Darier disease had a 4.3-fold elevated risk of being diagnosed with bipolar 
disorder, and a 2.3-fold elevated risk of being diagnosed with schizophrenia, 
compared with matched comparison subjects without Darier disease.  
In the family analysis, first-degree relatives to individuals with Darier disease had 
a 1.6-fold elevated risk of bipolar disorder, but there were less evidence of an 
excess risk of schizophrenia (Table 4.3.1).  
The additional family analyses, where only relatives without Darier disease were 
included, yielded expected results; there were no associations with neither 
schizophrenia (risk ratio 0.7, 95% confidence interval 0.3-1.6) nor bipolar 
disorder (risk ratio 1.1, 95% confidence interval 0.6-1.9). 
 
Table 4.3.1. Risks of bipolar disorder/schizophrenia in individuals with 
(exposed) vs. without (unexposed) Darier disease, and their first-degree 
relatives.  
 Bipolar disorder 
 
Schizophrenia 
 Exposed 
n (%) 
Unexpose
d 
n (%) 
RR 
(CI) 
Exposed 
n (%) 
Unexpose
d 
n (%) 
RR 
(CI) 
Individuals 15 
(2.0) 
351 
(0.5) 
4.3 
(2.6-
7.3) 
6 
(0.8) 
261 
(0.3) 
2.3 
(1.1-
5.2) 
1st degree 
relatives 
21 
(0.7) 
1 028 
(0.4) 
1.6 
(1.1-
2.5) 
7 
(0.2) 
657 
(0.2) 
0.8 
(0.4-
1.8) 
Note: statistically significant risk ratios are shown in bold. RR = risk ratios, CI = 95% 
confidence intervals. 
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4.4 STUDY IV – CONSEQUENCES OF PSYCHOTIC 
EXPERIENCES 
Study IV is a prospective cohort study, just like study I and II. The study is based 
on 8,407 twins who were members of the CATSS-15 and/or the CATSS-18 
studies. The study participants were linked to the NPR to retrieve information 
about diagnoses of drug use disorder and suicide attempt, assigned after the 
CATSS-15 or CATSS-18 questionnaires were completed. Hazard rates of these 
adverse outcomes were then compared between adolescents who did versus did 
not report distinct psychotic experiences at ages 15 or 18 years. The psychotic 
experiences were auditory and visual hallucinations and delusions of persecution, 
reference, control, special powers, and thought broadcasting. We further 
examined the relationship between the number of reported psychotic 
experiences in relation to risk of later diagnoses of drug use disorder. Because 
distributional problems prohibited this analysis for suicide attempt, we instead 
used a composite score as a predictor variable. There were different response 
alternatives for different items, so answers were dichotomized so that 1 score 
equaled 1 one psychotic experience. Participants were followed from the date 
they completed the CATSS-15 or 18 questionnaires; those who participated in 
both studies were followed from the CATSS-15 study. Because of the survival 
data structure, associations were examined with Cox proportional hazard 
regression models. As correlated twin pairs were used in the analyses, a robust 
sandwich estimator was applied to control for the correlated data structure when 
calculating the confidence intervals. 
4.4.1 Results 
After adjusting for the potential confounding effect of sex and low parental 
education level, adolescents who reported psychotic experiences had excess 
hazards of later drug use disorder or suicide attempt (Table 4.4.1). Further, there 
was a dose-response relationship between the number of psychotic experiences 
and later drug use disorder (Table 4.4.2). When the composite score was used as 
a predictor variable, the hazard of later drug use disorder and suicide attempt 
increased by 1.4 and 1.2 times respectively, for each psychotic experience (Table 
4.4.2). 
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Table 4.4.1. Hazard ratios and 95% confidence intervals (CI) of drug use 
disorder and suicide attempts in adolescents with distinct psychotic 
experiences at ages 15 or 18 years. 
 Later drug use disorder Later suicide 
 attempt 
Ages 15 or 18 years 
psychotic experiences 
CHR (CI) AHR (CI) CHR (CI) AHR (CI) 
Auditory hallucinations 3.2  
(1.3-7.6) 
3.3 
 (1.4-7.9) 
2.9 
(1.8-4.7) 
3.0 
(1.8-4.9) 
Visual hallucinations 2.6  
(1.4-4.9) 
2.6  
(1.4-5.0) 
2.1  
(1.4-3.4) 
2.1  
(1.3-3.3) 
Being spied upon 3.1 
 (1.5-6.4) 
3.3 
(1.7-6.4) 
1.3 
 (0.8-2.0) 
1.4  
(0.9-2.1) 
Thought broadcasting 2.0  
(1.1-4.0) 
2.0  
(1.1-4.0) 
1.5 
 (0.9-2.3) 
1.5  
(0.9-2.3) 
Being sent special messages  
through TV 
1.5 
 (0.4-4.9) 
1.5  
(0.4-4.9) 
1.9  
(0.9-3.8) 
1.8 
(0.9-3.7) 
Having special powers 2.4 
 (1.1-5.4) 
2.4  
(1.1-5.5) 
2.0  
(1.1-3.6) 
1.9 
(1.1-3.5) 
Being controlled by some  
special power 
1.7  
(0.7-3.9) 
1.7  
(0.7-3.8) 
2.3  
(1.4-3.8) 
2.3 
(1.4-3.9) 
Note: Statistically significant associations are bolded. CHR= crude hazard ratio, AHR= 
adjusted hazard ratio. 
Table 4.4.2. Associations between the number of psychotic 
experiences and later drug use disorder, and suicide 
attempt. 
 Later drug use 
disorder 
Later suicide 
attempt 
Age 15/18 years 
psychotic experiences 
HR (CI) HR (CI) 
0 (reference)   
1  0.9  
(0.4-2.4) 
n/a 
2  2.0  
(0.8-5.1) 
n/a 
3  3.3  
(1.3-8.4) 
n/a 
4  6.6  
(2.6-16.8) 
n/a 
5  9.3 
 (3.2-27.3) 
n/a 
6  n/a n/a 
7  n/a n/a 
Composite score 1.4 
 (1.2-1.6) 
1.2 
 (1.1-1.3) 
Note: Statistically significant associations are bolded. A total of 100 individuals were excluded 
from the analysis due to missing data.  
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5 DISCUSSION 
5.1 PSYCHOTIC EXPERIENCES AS 
NEURODEVELOPMENTAL PHENOMENA 
The findings from studies I and II clearly indicate that adolescent psychotic 
experiences are neurodevelopmental phenomena. This is because childhood 
problems widely accepted as neurodevelopmental in origin, i.e., communication 
problems, reading problems, autistic traits, and a general neuropsychiatric 
problems factor, were associated with adolescent psychotic experiences. In the 
same vein, it was observed that the crude association between childhood autistic 
traits and adolescent psychotic experiences was better explained by the general 
neuropsychiatric problems factor. 
These results are generally in keeping with prior studies (Jones et al., 2012; 
Happé et al. 2012; Sullivan et al., 2013; Hameed et al., 2013; Khandaker et al., 
2014) and provide evidence for a neurodevelopmental continuity between 
adolescent psychotic experiences and clinical schizophrenia, for which the 
studied childhood problems are established risk factors (e.g. Kolvin et al., 1971; 
Crow et al., 1995; Hollis, 1995; Cannon et al., 2002; Rapoport et al., 2009). As far 
as I am aware, the association between a broad, general factor of childhood 
neuropsychiatric problems comprising symptoms of ADHD, developmental 
coordination disorder, tic disorder, and learning disorder, and adolescent 
auditory hallucinations has not been demonstrated before. Hence, findings from 
this thesis suggest that the heuristically important neurodevelopmental model of 
schizophrenia (Murray & Lewis, 1987; Weinberger, 1987; Rapoport et al., 2005) 
can be applied also on psychotic experiences in the general adolescent 
population. Further, the findings also suggest that adolescents reporting 
psychotic experiences, which is a considerably larger group than clinical cases, is 
a potentially valuable population for research into the etiology of schizophrenia. 
For example, longitudinal neuroscience research based on adolescents reporting 
psychotic experiences might provide important clues to the pathogenesis of 
schizophrenia, as the vast majority of these adolescents are not treated with 
psychotropic drugs (Rössler et al., 2011), are typically years before a possible 
prodrome (Polanczyk et al., 2010), and considerably easier to access than 
individuals with schizophrenia, which enables population-based studies. 
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I studied a genetically informative sample of twins, and through the use of 
structural equation modeling, findings from both studies I and II showed that 
the associations between neuropsychiatric problems and adolescent psychotic 
experiences were essentially only due to genetic factors, whereas environmental 
factors were negligible. In other words, the same set of genes seems to be 
involved in the pathogenesis of a broad spectrum of neuropsychiatric problems 
in childhood, as well as in susceptibility to psychotic experiences in mid-and late 
adolescence. To my best knowledge, this was the first demonstration of the 
importance of shared genetic factors for associations between these childhood 
and adolescent problems. Further, these genetic correlations are consistent with 
the overarching trend in molecular psychiatry research, namely that risk alleles 
confer liability for a range of psychiatric disorders (Cross Disorder Group of the 
Psychiatric Genomics Consortium, 2013). 
5.2 THE POPULATION ASSOCIATION BETWEEN DARIER 
DISEASE AND BIPOLAR DISORDER, AND 
SCHIZOPHRENIA 
Findings from study II document that the risk of bipolar disorder and 
schizophrenia is markedly elevated in individuals with diagnosed Darier disease 
in Sweden. Further, the risk of bipolar disorder was increased also in individuals 
with a first-degree relative who had Darier disease, but not when relatives who 
had Darier disease themselves were excluded from the analysis.  
Earlier studies have demonstrated a familial co-segregation of Darier disease and 
bipolar disorder, and schizophrenia (Getzler & Flint, 1966; Craddock et al., 1994; 
Jones et al., 2002). The findings observed in this study extends these findings 
which were observed in occasional pedigrees, and provides evidence for an 
tendency towards a familial co-segregation of Darier disease and bipolar disorder 
in the Swedish general population. 
Several splicing, frame shift, missense, and nonsense mutations have been 
documented in the Darier-causing ATP2A2 gene (Jacobsen et al., 1999; 
Sakuntabhai et al., 1999; Ruiz-Perez et al., 1999).This gene is involved in synaptic 
plasticity and neurotransmission (Berridge, Bootman, and Lipp, 1998), and is 
important in intracellular calcium signaling (Lytton & MacLennan, 1988). 
Genome-wide association studies have shown that calcium channels are involved 
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in psychopathology, especially bipolar disorder and schizophrenia (Cross 
Disorder Group of the Psychiatric Genomics Consortium, 2013; Ripke et al., 
2013). Further, calcium homeostasis defects seem to be involved in bipolar 
disorder, and pharmacological treatment for the disorder might be elicited 
through intracellular calcium changes (Emamghoreishi et al., 1997). Hence, the 
ATP2A2 gene is a robust functional candidate gene for bipolar disorder, but also 
for schizophrenia. Interestingly, this was recently confirmed in a large genome-
wide association study (Schizophrenia Working Group of the Psychiatric 
Genomics Consortium, 2014).  
Taken together, the results in this study strongly suggest that the ATP2A2 gene 
produce liability for bipolar disorder in particular, but also for schizophrenia. 
The Darier-causing mutations merit in-depth attention in molecular genetic 
studies of psychiatric disorders. 
5.3 ADOLESCENT PSYCHOTIC EXPERIENCES AS 
PREDICTORS OF LATER DRUG USE DISORDER, AND 
SUICIDE ATTEMPT 
The findings from study IV showed that adolescent psychotic experiences were 
associated with elevated risks of later development of two particularly adverse 
outcomes, namely diagnosed drug use disorder and diagnosed suicide attempt.  
Prior studies have shown that adolescents who report auditory hallucinations, 
but not visual hallucinations, have 8-fold elevated risks of later substance misuse 
in early adulthood (Dhossche et al., 2002). Suicidal behaviors like self-reported 
suicidal ideations (Kelleher, Cederlöf, and Lichtenstein 2014b), self-reported 
suicide attempts (Kelleher et al., 2013a), and diagnosed suicide attempt (Fisher et 
al., 2013) have also been reported in adolescents with auditory hallucinations or a 
composite of auditory hallucinations and four delusions.  
Our results are generally congruent with previous research, and additionally 
show that longitudinal risks of drug use disorder and suicide attempt are not 
confined to auditory hallucinations or to psychotic experiences above some 
arbitrary, distribution-based cutoff level, as in a prior study based on data from 
the Dunedin cohort (Fisher et al., 2013). Our data is also consistent with a recent 
study, in which psychotic experiences were categorized into hallucinations, 
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delusions, and both hallucinations and delusions, and where no meaningful 
differences were detected regarding the effect on subsequent self-reported 
suicide attempt (Sullivan et al., 2015). In the current dataset, all distinct psychotic 
experiences were associated with later diagnosed drug use disorder and/or 
suicide attempt. Further, for the first time, evidence for a dose-response 
relationship between the number of reported psychotic experiences and drug use 
disorder was presented. 
Suicide attempts were measured with diagnoses assigned by physicians at 
discharge from a hospital ward, or at a visit at a specialist psychiatric clinic. This 
particular measure might have more severe clinical properties than self-reported 
suicide attempt. This is because, most probably, only a fraction of all suicide 
attempts are registered in the National Patient Register. Hence, we could here 
show that psychotic experiences are predictive of severe suicide attempt, which 
have clinical implications. 
5.4 METHODOLOGICAL CONSIDERATIONS 
5.4.1 Surveillance bias 
Surveillance bias, or detection bias, is a form of non-random misclassification 
bias that refers to a situation where one group is more closely monitored than 
another group. The results in study III may have been affected by such bias to 
an extent that cannot be estimated. This is because individuals with Darier 
disease probably are more likely to be diagnosed with schizophrenia or bipolar 
disorder than the comparison individuals due to their interactions with health 
care. Because of the ample evidence suggesting true associations between these 
disorders, and because of the plausible underlying biological mechanism, the 
magnitude of the possible influence of surveillance bias in the observed 
associations between Darier disease and schizophrenia and bipolar disorder, was 
probably marginal. 
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5.4.2 Assumptions of the twin method 
The twin method relies on a number of assumptions, for example that 1) MZ 
and DZ twin pairs share their environment equally (the “equal environments 
assumption”). Other assumptions include that 2), there is no correlation between 
genes and environments in the trait/traits under study, 3), there are no 
differences between twins and singletons in the trait, 4), mating occur randomly 
in the population (the “assortative mating assumption”) and DZ twins pairs 
therefore share 50% of their segregating genes. 
 Violations of assumptions of the twin method 5.4.2.1
Violation of assumption 1), for example in a situation where MZ twin pairs are 
treated more similarly by their caregivers than DZ twin pairs, will consequently 
result in an incorrect inflation of the estimate of A. 
Violation of assumption 3) may bias the estimates of either A, C or E, depending 
on how singletons differ from twins in the trait/traits under study. If assumption 
4) is violated and the genetic relatedness of DZ twins exceeds 0.5, this results in 
an inflation of the C estimate. These assumptions may, or may not, be realistic 
and can have important implications for the interpretation of the results, 
depending on the studied trait/traits and the research question (Rijsdijk & Sham, 
2002, Verweij et al., 2012).  
Empirical evidence has shown that the influence of the equal environments 
assumptions is minimal (Felson, 2014), I am not aware of any data suggesting 
any differences between twins and singletons regarding psychotic experiences, 
and simulations have shown that the influence of assortative mating bias is 
modest (Barnes et al., 2014). Hence, bias from twin methodology is not likely to 
be a major problem in this thesis. 
5.5 ETHICAL CONSIDERATIONS 
All studies in this thesis were approved by the Regional Ethics Review Board in 
Stockholm. In medical research, researchers have to weigh the benefits of the 
research against the welfare of the study participants. Observational register-
based studies, such as all studies in this thesis, are generally less ethically 
challenging than experimental studies, because data is collected without 
intervention. However, is it still possible that some questions to both children 
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and parents in the CATSS studies may have elicited a negative reaction, such as 
shame, anxiety or worry. Therefore, both parents and children, who gave 
informed consent to participate, were offered contact with a licensed 
psychologist. Further, all studies used sensitive personal information that 
potentially can detriment the personal integrity of the participants. Therefore, 
and in accordance with Swedish law (Swedish parliament, 2003), the identity of 
the participants (i.e., personnummer) was protected by the use of a unique 
identification code number (löpnummer and/or tvillingnummer). 
5.6 CLINICAL IMPLICATIONS 
As researchers have noted, answering questions about psychotic experiences may 
identify several perceptual phenomena with highly varying degrees of clinical 
relevance, which makes research findings potentially problematic to translate 
into practice (e.g. Garralda, 2016). However, validation studies have shown that 
endorsement of auditory hallucinations predict clinically verifiable psychotic 
experiences (Horwood et al., 2008; Kelleher et al., 2011a). Still, robust and 
replicated results are needed before changes in the clinical management of 
adolescents with psychotic experiences are considered. 
Findings from studies I and II suggests that clinical practice may indeed be 
enhanced through consideration of childhood, but also co-existing, problems 
with communication, reading and mathematics, as well as general 
neuropsychiatric problems, in adolescents with psychotic experiences, as they 
likely have a negative impact on broad patient function. Further, it is conceivable 
that the monitoring of children with these childhood neurodevelopmental 
problems may facilitate early identification of psychotic experiences (as well as 
juvenile mania symptoms), which may reduce their possible negative 
consequences.  
Regarding individuals with Darier disease: in our cohort, 2.0 % had a diagnosis 
of bipolar disorder and 0.8% had a diagnosis of schizophrenia. These psychiatric 
disorders rarely escape detection. Nevertheless, a much larger proportion of 
individuals with Darier disease might very well have subclinical affective and/or 
psychotic symptoms. More research is needed, but dermatologists and other 
health care professionals who meet patients with this disorder should be alert to 
changes in the behavior and mental states of their patients. 
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The findings from the thesis suggest that psychotic experiences should be 
enquired in psychiatric examinations of children and adolescents. Careful and 
ethically considered monitoring of adolescents reporting psychotic experiences 
may at best reduce their risk of developing a psychotic disorder, a drug use 
disorder, or a suicidal attempt. At least, such prevention strategies would likely 
facilitate early detection of these adverse conditions. Hence, results from studies 
I, II and IV might have bearing for both primary prevention (prevention of 
disorder occurrence) and secondary prevention (minimizing time to detection 
and treatment of disorder) strategies in clinical psychiatry. Finally, clinicians 
should include both hallucinations and delusions when assessing psychotic 
experiences in adolescents. 
5.7 CONCLUDING REMARKS 
The population-based, genetically sensitive designs, and bi-directional approach 
to research into the risk, correlates and consequences of the extended psychosis 
phenotype yielded replications of prior research as well as a number of novel 
findings: adolescent psychotic experiences (and to some extent juvenile mania 
symptoms) are characterized by developmental deviations in areas of 
communication, reading, mathematics, and neuropsychiatric problems in general. 
Further, these associations between childhood and adolescent problems share a 
common etiology of a primarily genetic origin. It can also be concluded that 
there is a population association between Darier disease and schizophrenia and 
bipolar disorder. Finally, adolescent psychotic experiences are associated with 
elevated risks of later diagnoses of drug use disorder, and suicide attempt. 
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6 SVENSK SAMMANFATTNING 
Psykossjukdomar innebär ett avsevärt lidande för de drabbade och deras 
familjer. Av hävd betraktas dessa sjukdomar som diagnosticerbara ”ting” som 
man antingen har eller inte har. Denna syn på psykossjukdomar har dock börjat 
ifrågasättas, eftersom forskning har visat att psykosliknande upplevelser är 
vanliga, speciellt bland ungdomar. Trots en hel del forskning vet man fortfarande 
relativt lite om orsaker, korrelat och konsekvenser av psykossjukdomar och 
psykosliknande upplevelser. Målet med denna avhandling var därför att vidare 
undersöka möjliga riskfaktorer, korrelat och konsekvenser av dessa fenomen. 
I studie I och II användes tvillingstudien The Child and Adolescent Twin Study 
in Sweden (CATSS) för att undersöka om neuropsykiatriska problem i 
barndomen ökar risken för psykosliknande upplevelser i tonåren. Genom 
tvillinganalyser kartlades de genetiska och miljömässiga influenserna bakom 
sambanden. Vi fann att problem med språk och matematik ökade risken för 
psykosliknande upplevelser i tonåren. Vi fann också ett samband mellan 
autistiska drag och psykosliknande upplevelser, men detta specifika samband 
visade sig kunna förklaras av generella neuropsykiatriska problem snarare än 
autistiska drag i sig. Tvillinganalyserna visade att sambanden mellan 
barndomsproblemen och psykosliknande upplevelser till största delen 
influerades av genetiska faktorer.  
I studie III använde vi Patientregistret för att undersöka om Dariers sjukdom, en 
ovanlig hudsjukdom, är kopplat till risk för schizofreni och bipolär sjukdom. 
Denna hypotes grundar sig i att hud och hjärna bildas ur samma groddblad i 
embryots tidiga utveckling. Vi fann att personer med Dariers sjukdom hade en 
fördubblad risk att bli diagnosticerade med schizofreni, och en fyrfaldigt förhöjd 
risk att bli diagnosticerade med bipolär sjukdom.  
I den fjärde och sista studien länkade vi CATSS-studien mot Patientregistret för 
att undersöka konsekvenser av psykosliknande upplevelser i tonåren. Det visade 
sig att tonåring som rapporterat dessa upplevelser löpte en förhöjd risk att senare 
bli diagnosticerade med missbruksproblem eller självmordsförsök. 
´ 
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Sammanfattningsvis fann vi att psykosliknande upplevelser i tonåren präglas av 
utvecklingsmässiga problem i barndomen och att dessa två typer av problem 
delar en gemensam genetisk grund. Vidare fann vi ett samband mellan Dariers 
sjukdom och schizofreni och bipolär sjukdom i befolkningen. Slutligen fann vi 
att psykosliknande upplevelser i tonåren är associerade med senare missbruk och 
suicidförsök. Dessa resultat stöder ledande förklaringsmodeller för orsakerna 
bakom psykossjukdomar och betonar vikten av att följa upp tonåringar med 
psykosliknande upplevelser. 
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